List of PASS biological activities types
| Activity | ROC AUC, LOO CV | Number of Compounds | Type |
|---|---|---|---|
| 143B | 0.93 | 45 | Cell Line |
| 184B5 | 1.0 | 3 | Cell Line |
| 1A9 | 0.99 | 93 | Cell Line |
| 1A9/ptx-10 | 0.99 | 36 | Cell Line |
| 1A9/ptx-22 | 0.99 | 24 | Cell Line |
| 2008 | 0.86 | 4 | Cell Line |
| 4T1 | 0.89 | 37 | Cell Line |
| 518A2 | 1.0 | 38 | Cell Line |
| 5637 | 0.84 | 167 | Cell Line |
| 786-0 | 0.88 | 981 | Cell Line |
| 833K | 0.99 | 16 | Cell Line |
| 8505C | 0.83 | 129 | Cell Line |
| A172 | 0.81 | 6 | Cell Line |
| A-375 | 0.93 | 1407 | Cell Line |
| A-427 | 0.87 | 210 | Cell Line |
| A-431 | 0.94 | 1547 | Cell Line |
| A121 | 1.0 | 80 | Cell Line |
| A2058 | 0.86 | 109 | Cell Line |
| A2780 | 0.93 | 2930 | Cell Line |
| A2780/T | 0.96 | 29 | Cell Line |
| A2780S | 0.85 | 13 | Cell Line |
| A2780cisR | 0.84 | 3 | Cell Line |
| A498 | 0.89 | 1046 | Cell Line |
| A549 | 0.86 | 15040 | Cell Line |
| A549/CDDP | 1.0 | 23 | Cell Line |
| A549/TR | 0.96 | 26 | Cell Line |
| ACHN | 0.9 | 1582 | Cell Line |
| ADR5000 | 0.91 | 11 | Cell Line |
| AG1523 | 0.96 | 25 | Cell Line |
| AGS | 0.88 | 310 | Cell Line |
| ARPE-19 | 1.0 | 48 | Cell Line |
| ASPC1 | 0.9 | 234 | Cell Line |
| ATH-8 | 0.96 | 3 | Cell Line |
| BE | 0.99 | 17 | Cell Line |
| BE-NQ | 1.0 | 15 | Cell Line |
| BEAS-2B | 1.0 | 9 | Cell Line |
| BGC-823 | 0.97 | 92 | Cell Line |
| BHK-21 | 0.91 | 15 | Cell Line |
| BJ | 0.95 | 150 | Cell Line |
| BT-474 | 0.94 | 625 | Cell Line |
| BT-549 | 0.88 | 839 | Cell Line |
| BV-2 | 0.96 | 44 | Cell Line |
| BXPC-3 | 0.92 | 485 | Cell Line |
| Bcap37 | 0.98 | 109 | Cell Line |
| Bel-7402 | 0.97 | 133 | Cell Line |
| Bel7402/5-FU | 0.97 | 28 | Cell Line |
| C180-13S | 1.0 | 11 | Cell Line |
| C6 | 0.98 | 8 | Cell Line |
| C8166 | 0.84 | 105 | Cell Line |
| CA46 | 0.81 | 98 | Cell Line |
| CAKI-1 | 0.88 | 979 | Cell Line |
| CAKI-2 | 0.83 | 5 | Cell Line |
| CAL-27 | 0.85 | 113 | Cell Line |
| CAL-51 | 0.82 | 117 | Cell Line |
| CAPAN-1 | 0.89 | 149 | Cell Line |
| CCD-18Co | 0.99 | 261 | Cell Line |
| CCRF-CEM | 0.91 | 3625 | Cell Line |
| CCRF-CEM/VCR-1000 | 0.99 | 62 | Cell Line |
| CCRF-HSB-2 | 0.94 | 23 | Cell Line |
| CCRF-SB | 0.97 | 91 | Cell Line |
| CEM-DNR | 0.95 | 12 | Cell Line |
| CEM-SS | 0.98 | 142 | Cell Line |
| CEM-c113 | 1.0 | 4 | Cell Line |
| CEM/C2 | 0.93 | 17 | Cell Line |
| CFPAC-1 | 0.91 | 84 | Cell Line |
| CL1-0 | 0.83 | 4 | Cell Line |
| CL97 | 0.87 | 6 | Cell Line |
| CNE | 0.99 | 4 | Cell Line |
| CNE-2 | 0.99 | 4 | Cell Line |
| CNE2Z | 1.0 | 3 | Cell Line |
| COLO-205 | 0.9 | 1700 | Cell Line |
| COLO-320 | 1.0 | 10 | Cell Line |
| COLO-320DM | 0.99 | 64 | Cell Line |
| COLO357 | 1.0 | 11 | Cell Line |
| COR-L23 | 0.83 | 115 | Cell Line |
| CPT30 | 1.0 | 7 | Cell Line |
| CRL-7065 | 0.93 | 9 | Cell Line |
| CT26 | 0.87 | 15 | Cell Line |
| CWR22R | 0.91 | 303 | Cell Line |
| Cac-2 | 0.93 | 345 | Cell Line |
| Caco-2 | 0.9 | 47 | Cell Line |
| Calu-1 | 0.85 | 85 | Cell Line |
| Caov-3 | 0.89 | 7 | Cell Line |
| Capan-2 | 0.9 | 13 | Cell Line |
| Cav-3 | 0.94 | 57 | Cell Line |
| Col2 | 1.0 | 3 | Cell Line |
| CuFi-1 | 1.0 | 3 | Cell Line |
| D54 | 0.99 | 4 | Cell Line |
| DAN-G | 0.96 | 54 | Cell Line |
| DLD-1 | 0.95 | 724 | Cell Line |
| DMS-114 | 0.83 | 124 | Cell Line |
| DO4 | 1.0 | 6 | Cell Line |
| DU-145 | 0.9 | 4562 | Cell Line |
| DU-4475 | 0.8 | 125 | Cell Line |
| Daoy | 0.91 | 21 | Cell Line |
| Daudi | 0.99 | 31 | Cell Line |
| Detroit562 | 0.99 | 5 | Cell Line |
| EA.hy926 | 0.97 | 20 | Cell Line |
| EBC-1 | 0.94 | 19 | Cell Line |
| ECa-109 | 0.96 | 94 | Cell Line |
| EJ | 1.0 | 9 | Cell Line |
| EKVX | 0.84 | 522 | Cell Line |
| EOL1 | 0.86 | 167 | Cell Line |
| FHC | 0.82 | 10 | Cell Line |
| FaDu | 0.9 | 254 | Cell Line |
| G-361 | 0.89 | 191 | Cell Line |
| G55T2 | 1.0 | 11 | Cell Line |
| GC3/Cl | 1.0 | 5 | Cell Line |
| GC3/M | 1.0 | 12 | Cell Line |
| GC3/MTK- | 1.0 | 13 | Cell Line |
| GES1 | 0.96 | 33 | Cell Line |
| GHOSTCXCR4 | 1.0 | 3 | Cell Line |
| GIST430 | 0.82 | 5 | Cell Line |
| GIST48 | 0.81 | 6 | Cell Line |
| GIST882 | 0.82 | 6 | Cell Line |
| GISTT1 | 0.94 | 32 | Cell Line |
| GLC4 | 1.0 | 10 | Cell Line |
| GM892A | 1.0 | 4 | Cell Line |
| Granta-519 | 0.99 | 23 | Cell Line |
| H2981 | 0.99 | 11 | Cell Line |
| H322 | 1.0 | 6 | Cell Line |
| H9 | 0.87 | 123 | Cell Line |
| H9c2 | 0.9 | 9 | Cell Line |
| HA22T | 0.95 | 21 | Cell Line |
| HBL | 0.94 | 10 | Cell Line |
| HBL-100 | 0.96 | 21 | Cell Line |
| HCC1806 | 0.82 | 108 | Cell Line |
| HCC1937 | 0.81 | 78 | Cell Line |
| HCC1954 | 0.83 | 94 | Cell Line |
| HCC2998 | 0.87 | 708 | Cell Line |
| HCC78 | 0.99 | 65 | Cell Line |
| HCC827 | 0.98 | 113 | Cell Line |
| HCT-116 | 0.89 | 10992 | Cell Line |
| HCT-116/VM46 | 1.0 | 104 | Cell Line |
| HCT-15 | 0.91 | 2078 | Cell Line |
| HCT-8 | 0.96 | 681 | Cell Line |
| HEC-1B | 1.0 | 11 | Cell Line |
| HEK-293T | 0.97 | 58 | Cell Line |
| HEK293 | 0.9 | 1110 | Cell Line |
| HEL | 0.9 | 302 | Cell Line |
| HEL299 | 0.9 | 4 | Cell Line |
| HET-1A | 1.0 | 4 | Cell Line |
| HEY | 0.97 | 34 | Cell Line |
| HFF | 0.95 | 27 | Cell Line |
| HFL1 | 1.0 | 309 | Cell Line |
| HGC-27 | 0.83 | 148 | Cell Line |
| HK-2 | 0.88 | 10 | Cell Line |
| HL-60 | 0.88 | 5486 | Cell Line |
| HL-60(TB) | 0.95 | 53 | Cell Line |
| HMEC-1 | 0.98 | 42 | Cell Line |
| HN5 | 0.99 | 75 | Cell Line |
| HONE1 | 1.0 | 5 | Cell Line |
| HOP-18 | 0.93 | 9 | Cell Line |
| HOP-62 | 0.9 | 1318 | Cell Line |
| HOP-92 | 0.86 | 679 | Cell Line |
| HOS | 0.86 | 161 | Cell Line |
| HOS-TE85 | 0.84 | 13 | Cell Line |
| HPAC | 0.93 | 28 | Cell Line |
| HRT-18 | 1.0 | 4 | Cell Line |
| HS27 | 0.97 | 41 | Cell Line |
| HT | 0.86 | 121 | Cell Line |
| HT-1080 | 0.92 | 534 | Cell Line |
| HT-29 | 0.89 | 7636 | Cell Line |
| HT1197 | 0.81 | 59 | Cell Line |
| HUVEC | 0.9 | 131 | Cell Line |
| HaCaT | 0.97 | 375 | Cell Line |
| HeLa | 0.89 | 8431 | Cell Line |
| HeLaS3 | 0.97 | 23 | Cell Line |
| Hep3B2 | 0.96 | 135 | Cell Line |
| Hep293TT | 0.99 | 13 | Cell Line |
| HepG2 | 0.87 | 7802 | Cell Line |
| HepG22.2.15 | 0.85 | 12 | Cell Line |
| HepG2-CD81 | 0.93 | 5768 | Cell Line |
| Hs-578T | 0.87 | 434 | Cell Line |
| Hs683 | 0.96 | 47 | Cell Line |
| Hs766 | 1.0 | 11 | Cell Line |
| HuCC-A1 | 0.88 | 16 | Cell Line |
| HuP-T3 | 0.87 | 62 | Cell Line |
| HuT78 | 0.98 | 40 | Cell Line |
| Huh-7 | 0.92 | 555 | Cell Line |
| IGROV-1 | 0.89 | 1116 | Cell Line |
| IMR-32 | 0.95 | 188 | Cell Line |
| IMR-90 | 0.88 | 18 | Cell Line |
| Ishikawa | 0.96 | 111 | Cell Line |
| JAM | 1.0 | 5 | Cell Line |
| JJN-3 | 1.0 | 17 | Cell Line |
| JY | 1.0 | 13 | Cell Line |
| JeKo-1 | 0.95 | 74 | Cell Line |
| Jurkat | 0.95 | 218 | Cell Line |
| JurkatE6.1 | 1.0 | 5 | Cell Line |
| K-562R | 0.87 | 14 | Cell Line |
| K562 | 0.89 | 6204 | Cell Line |
| K562/Adr | 0.97 | 13 | Cell Line |
| KARPAS-299 | 0.94 | 291 | Cell Line |
| KARPAS-422 | 0.88 | 128 | Cell Line |
| KB | 0.97 | 203 | Cell Line |
| KB3-1 | 0.96 | 22 | Cell Line |
| KB/VJ300 | 0.99 | 23 | Cell Line |
| KBM5 | 0.93 | 6 | Cell Line |
| KETR3 | 0.98 | 43 | Cell Line |
| KG-1 | 0.9 | 253 | Cell Line |
| KG-1a | 1.0 | 17 | Cell Line |
| KK-47 | 0.89 | 3 | Cell Line |
| KKLS | 1.0 | 4 | Cell Line |
| KM-20L2 | 1.0 | 4 | Cell Line |
| KM12 | 0.88 | 1049 | Cell Line |
| KM3/BTZ | 0.99 | 6 | Cell Line |
| KMS-12-BM | 1.0 | 4 | Cell Line |
| KOPTK1 | 0.81 | 5 | Cell Line |
| KYSE-520 | 0.86 | 83 | Cell Line |
| Kasumi-1 | 0.82 | 116 | Cell Line |
| L02 | 0.93 | 193 | Cell Line |
| L1210 | 0.98 | 183 | Cell Line |
| L132 | 1.0 | 4 | Cell Line |
| L2987 | 0.98 | 11 | Cell Line |
| L3.6pl | 0.98 | 3 | Cell Line |
| L5178Y | 0.96 | 18 | Cell Line |
| LAPC4 | 1.0 | 16 | Cell Line |
| LNCaP | 0.95 | 1665 | Cell Line |
| LNCaPC4-2 | 1.0 | 4 | Cell Line |
| LOXIMVI | 0.88 | 1010 | Cell Line |
| LS174T | 0.91 | 78 | Cell Line |
| LXFL529 | 0.98 | 13 | Cell Line |
| Leukemiacells | 0.9 | 14 | Cell Line |
| LoVo | 0.91 | 71 | Cell Line |
| Lu1 | 0.99 | 20 | Cell Line |
| M14 | 0.89 | 1203 | Cell Line |
| M19-MEL | 0.93 | 9 | Cell Line |
| M21 | 0.98 | 280 | Cell Line |
| M4Beu | 1.0 | 6 | Cell Line |
| MAXF401 | 0.98 | 6 | Cell Line |
| MCF-10A | 0.94 | 71 | Cell Line |
| MCF-12A | 0.99 | 7 | Cell Line |
| MCF7 | 0.84 | 15718 | Cell Line |
| MCF7R | 1.0 | 72 | Cell Line |
| MDA-MB-231 | 0.88 | 7364 | Cell Line |
| MDA-MB-361 | 0.87 | 174 | Cell Line |
| MDA-MB-435 | 0.95 | 101 | Cell Line |
| MDA-MB-436 | 0.93 | 29 | Cell Line |
| MDA-MB-453 | 0.89 | 233 | Cell Line |
| MDA-MB-468 | 0.9 | 1571 | Cell Line |
| MEC1 | 1.0 | 14 | Cell Line |
| MES-SA | 0.81 | 83 | Cell Line |
| MES-SA/Dx5 | 0.94 | 46 | Cell Line |
| MEXF276L | 0.81 | 4 | Cell Line |
| MGC-803 | 0.96 | 214 | Cell Line |
| MIAPaCa-2 | 0.92 | 854 | Cell Line |
| MKN-28 | 0.92 | 17 | Cell Line |
| MKN-45 | 0.94 | 812 | Cell Line |
| MKN-74 | 0.86 | 49 | Cell Line |
| MM1.S | 0.99 | 204 | Cell Line |
| MM96L | 1.0 | 64 | Cell Line |
| MOLM-13 | 0.97 | 186 | Cell Line |
| MOLM-14 | 0.89 | 8 | Cell Line |
| MOLT-3 | 0.98 | 90 | Cell Line |
| MOLT-4 | 0.89 | 1490 | Cell Line |
| MONO-MAC-6 | 0.81 | 92 | Cell Line |
| MR49F | 1.0 | 3 | Cell Line |
| MRC5 | 0.92 | 596 | Cell Line |
| MSTO-211H | 0.88 | 121 | Cell Line |
| MT2 | 0.96 | 101 | Cell Line |
| MT4 | 0.97 | 466 | Cell Line |
| MV4-11 | 0.95 | 1832 | Cell Line |
| MX1 | 0.97 | 243 | Cell Line |
| Mahlavu | 0.94 | 3 | Cell Line |
| Malme-3M | 0.88 | 712 | Cell Line |
| Maver1 | 0.93 | 31 | Cell Line |
| NALM-6 | 0.85 | 192 | Cell Line |
| NAMALVA | 0.99 | 35 | Cell Line |
| NB-4 | 0.95 | 174 | Cell Line |
| NCH82 | 1.0 | 6 | Cell Line |
| NCI-H128 | 0.91 | 16 | Cell Line |
| NCI-H1299 | 0.92 | 470 | Cell Line |
| NCI-H157 | 0.91 | 11 | Cell Line |
| NCI-H1581 | 0.87 | 146 | Cell Line |
| NCI-H1650 | 0.84 | 139 | Cell Line |
| NCI-H1703 | 0.85 | 86 | Cell Line |
| NCI-H187 | 0.85 | 88 | Cell Line |
| NCI-H1975 | 0.95 | 717 | Cell Line |
| NCI-H1993 | 0.91 | 146 | Cell Line |
| NCI-H2171 | 0.95 | 299 | Cell Line |
| NCI-H2228 | 0.92 | 237 | Cell Line |
| NCI-H226 | 0.88 | 868 | Cell Line |
| NCI-H2286 | 0.97 | 9 | Cell Line |
| NCI-H23 | 0.88 | 1192 | Cell Line |
| NCI-H292 | 0.84 | 142 | Cell Line |
| NCI-H295R | 0.86 | 11 | Cell Line |
| NCI-H3122 | 0.98 | 57 | Cell Line |
| NCI-H322M | 0.88 | 634 | Cell Line |
| NCI-H358 | 0.81 | 109 | Cell Line |
| NCI-H417 | 0.98 | 22 | Cell Line |
| NCI-H441 | 0.81 | 69 | Cell Line |
| NCI-H460 | 0.91 | 3810 | Cell Line |
| NCI-H508 | 0.99 | 10 | Cell Line |
| NCI-H520 | 0.84 | 112 | Cell Line |
| NCI-H522 | 0.88 | 1035 | Cell Line |
| NCI-H647 | 0.89 | 10 | Cell Line |
| NCI-H661 | 0.83 | 120 | Cell Line |
| NCI-H69 | 0.9 | 205 | Cell Line |
| NCI-H727 | 0.83 | 107 | Cell Line |
| NCI-H929 | 0.97 | 35 | Cell Line |
| NCI-N87 | 0.92 | 320 | Cell Line |
| NCI/ADR-RES | 0.91 | 98 | Cell Line |
| NHDF | 0.95 | 30 | Cell Line |
| NSCLC | 0.96 | 22 | Cell Line |
| NT2 | 0.99 | 58 | Cell Line |
| NUGC-3 | 0.93 | 288 | Cell Line |
| OCI-AML-3 | 0.98 | 14 | Cell Line |
| OCI-AML2 | 0.8 | 114 | Cell Line |
| OCI-Ly1 | 1.0 | 5 | Cell Line |
| OCI-Ly10 | 0.92 | 3 | Cell Line |
| OCI-Ly3 | 0.99 | 40 | Cell Line |
| OE33 | 0.81 | 56 | Cell Line |
| OPM-2 | 0.82 | 81 | Cell Line |
| OS-RC-2 | 0.81 | 117 | Cell Line |
| OVCAR-3 | 0.91 | 1728 | Cell Line |
| OVCAR-4 | 0.86 | 715 | Cell Line |
| OVCAR-5 | 0.87 | 617 | Cell Line |
| OVCAR-8 | 0.89 | 973 | Cell Line |
| OVXF1023 | 1.0 | 3 | Cell Line |
| OVXF1353 | 1.0 | 3 | Cell Line |
| PA-1 | 0.85 | 159 | Cell Line |
| PANC-1 | 0.93 | 728 | Cell Line |
| PBMC | 0.93 | 69 | Cell Line |
| PC-12 | 0.94 | 21 | Cell Line |
| PC-14 | 0.93 | 252 | Cell Line |
| PC-3 | 0.88 | 5760 | Cell Line |
| PC-3M | 0.87 | 7 | Cell Line |
| PC-9 | 0.95 | 130 | Cell Line |
| PLC-PRF-5 | 0.83 | 50 | Cell Line |
| PNT1A | 0.88 | 8 | Cell Line |
| PT-45 | 0.94 | 20 | Cell Line |
| Panc203 | 1.0 | 6 | Cell Line |
| Panc430 | 1.0 | 8 | Cell Line |
| Pfeiffer | 0.99 | 35 | Cell Line |
| QG-56 | 1.0 | 90 | Cell Line |
| QGY-7703 | 0.98 | 48 | Cell Line |
| RCC4 | 0.84 | 3 | Cell Line |
| RD | 0.83 | 104 | Cell Line |
| RKO | 0.88 | 343 | Cell Line |
| RL | 0.83 | 43 | Cell Line |
| RPMI-7951 | 0.85 | 130 | Cell Line |
| RPMI-8226 | 0.88 | 1013 | Cell Line |
| RS4-11 | 0.83 | 198 | Cell Line |
| RWLeu4 | 1.0 | 9 | Cell Line |
| RWPE-1 | 0.92 | 28 | Cell Line |
| RXF393 | 0.87 | 795 | Cell Line |
| RXF944 | 0.99 | 8 | Cell Line |
| Raji | 0.94 | 430 | Cell Line |
| Ramos | 0.96 | 189 | Cell Line |
| Rec1 | 1.0 | 22 | Cell Line |
| S1B1-20 | 1.0 | 38 | Cell Line |
| SEM | 1.0 | 21 | Cell Line |
| SF-268 | 0.89 | 1287 | Cell Line |
| SF-295 | 0.88 | 1016 | Cell Line |
| SF-539 | 0.89 | 1104 | Cell Line |
| SGC-7901 | 0.96 | 128 | Cell Line |
| SH-SY5Y | 0.93 | 380 | Cell Line |
| SISO | 0.95 | 28 | Cell Line |
| SJSA-1 | 0.94 | 398 | Cell Line |
| SK-BR-3 | 0.95 | 1479 | Cell Line |
| SK-HEP1 | 0.91 | 234 | Cell Line |
| SK-LU-1 | 0.81 | 80 | Cell Line |
| SK-MEL-1 | 0.81 | 64 | Cell Line |
| SK-MEL-103 | 1.0 | 3 | Cell Line |
| SK-MEL-2 | 0.89 | 1048 | Cell Line |
| SK-MEL-28 | 0.88 | 1160 | Cell Line |
| SK-MEL-5 | 0.9 | 1037 | Cell Line |
| SK-MES-1 | 0.83 | 127 | Cell Line |
| SK-N-SH | 0.95 | 213 | Cell Line |
| SK-OV-3 | 0.9 | 2424 | Cell Line |
| SKM-1 | 0.92 | 66 | Cell Line |
| SKW6.4 | 1.0 | 40 | Cell Line |
| SMMC-7721 | 0.96 | 298 | Cell Line |
| SN12C | 0.9 | 1176 | Cell Line |
| SNB-19 | 0.95 | 76 | Cell Line |
| SNB-7 | 1.0 | 4 | Cell Line |
| SNB-75 | 0.88 | 871 | Cell Line |
| SNU-16 | 0.85 | 65 | Cell Line |
| SNU-398 | 0.97 | 74 | Cell Line |
| SNU-475 | 0.82 | 22 | Cell Line |
| SNU-5 | 0.83 | 97 | Cell Line |
| SNU-638 | 0.97 | 170 | Cell Line |
| SPC-A4 | 1.0 | 10 | Cell Line |
| SQ20B | 0.96 | 33 | Cell Line |
| SR | 0.88 | 944 | Cell Line |
| SU-DHL-6 | 0.99 | 71 | Cell Line |
| SU-DHL-8 | 0.85 | 4 | Cell Line |
| SUD4 | 0.81 | 14 | Cell Line |
| SUM-159-PT | 0.98 | 31 | Cell Line |
| SUM149PT | 0.98 | 3 | Cell Line |
| SUM185PE | 0.96 | 11 | Cell Line |
| SUNE1 | 1.0 | 3 | Cell Line |
| SW-1736 | 0.99 | 80 | Cell Line |
| SW-620 | 0.89 | 1845 | Cell Line |
| SW1116 | 0.86 | 46 | Cell Line |
| SW1353 | 0.94 | 41 | Cell Line |
| SW1573 | 0.92 | 228 | Cell Line |
| SW1990 | 0.88 | 108 | Cell Line |
| SW48 | 0.81 | 101 | Cell Line |
| SW480 | 0.93 | 846 | Cell Line |
| SiHa | 0.86 | 28 | Cell Line |
| Sku1B | 1.0 | 6 | Cell Line |
| T-24 | 0.93 | 297 | Cell Line |
| T47D | 0.94 | 461 | Cell Line |
| T98 | 1.0 | 5 | Cell Line |
| T98G | 0.91 | 21 | Cell Line |
| TERT-RPE1 | 0.94 | 31 | Cell Line |
| TF-1 | 0.97 | 34 | Cell Line |
| THP-1 | 0.94 | 1482 | Cell Line |
| TK-10 | 0.85 | 731 | Cell Line |
| TMD8 | 0.81 | 7 | Cell Line |
| TOV112D | 1.0 | 4 | Cell Line |
| TSGH9201 | 1.0 | 18 | Cell Line |
| TSU | 0.95 | 15 | Cell Line |
| U-251 | 0.88 | 1478 | Cell Line |
| U-266 | 0.87 | 147 | Cell Line |
| U-87MG | 0.92 | 622 | Cell Line |
| U-937 | 0.93 | 138 | Cell Line |
| U-937/GTB | 0.85 | 10 | Cell Line |
| U2OS | 0.89 | 299 | Cell Line |
| UACC-257 | 0.86 | 571 | Cell Line |
| UACC-375 | 0.99 | 86 | Cell Line |
| UACC-62 | 0.9 | 1217 | Cell Line |
| UACC-903 | 0.95 | 38 | Cell Line |
| UCLAP-3 | 1.0 | 5 | Cell Line |
| UMSCC22B | 1.0 | 4 | Cell Line |
| UMUC3 | 0.81 | 86 | Cell Line |
| UO-31 | 0.88 | 745 | Cell Line |
| VCaP | 0.98 | 86 | Cell Line |
| WI-38 | 0.94 | 288 | Cell Line |
| WIL2 | 1.0 | 39 | Cell Line |
| WIL2-NS | 0.98 | 49 | Cell Line |
| WM266-4 | 0.98 | 17 | Cell Line |
| WM164 | 0.96 | 18 | Cell Line |
| WiDr | 0.89 | 23 | Cell Line |
| XF498 | 0.96 | 98 | Cell Line |
| Y79 | 0.96 | 14 | Cell Line |
| YAPC | 0.82 | 50 | Cell Line |
| Z-138 | 0.93 | 51 | Cell Line |
| ZR-75-1 | 0.96 | 242 | Cell Line |
| 1,3-Beta-glucan synthase inhibitor | 1.0 | 436 | Mechanism of action |
| 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.99 | 713 | Mechanism of action |
| 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 1.0 | 97 | Mechanism of action |
| 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.99 | 4421 | Mechanism of action |
| 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 1.0 | 346 | Mechanism of action |
| 12-Lipoxygenase inhibitor | 0.91 | 859 | Mechanism of action |
| 15-Lipoxygenase inhibitor | 0.88 | 2432 | Mechanism of action |
| 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.99 | 364 | Mechanism of action |
| 2-Acylglycerol O-acyltransferase 2 inhibitor | 1.0 | 277 | Mechanism of action |
| 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.99 | 101 | Mechanism of action |
| 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.99 | 121 | Mechanism of action |
| 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.98 | 26 | Mechanism of action |
| 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.99 | 176 | Mechanism of action |
| 3C-like protease (Human coronavirus) inhibitor | 0.94 | 105 | Mechanism of action |
| 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 1.0 | 296 | Mechanism of action |
| 5 Hydroxytryptamine 1 agonist | 0.99 | 3101 | Mechanism of action |
| 5 Hydroxytryptamine 1 antagonist | 0.98 | 7503 | Mechanism of action |
| 5 Hydroxytryptamine 1A agonist | 0.99 | 1701 | Mechanism of action |
| 5 Hydroxytryptamine 1A antagonist | 0.98 | 5764 | Mechanism of action |
| 5 Hydroxytryptamine 1B agonist | 0.99 | 135 | Mechanism of action |
| 5 Hydroxytryptamine 1B antagonist | 0.98 | 1516 | Mechanism of action |
| 5 Hydroxytryptamine 1D agonist | 1.0 | 831 | Mechanism of action |
| 5 Hydroxytryptamine 1D antagonist | 0.99 | 1518 | Mechanism of action |
| 5 Hydroxytryptamine 1E antagonist | 0.93 | 69 | Mechanism of action |
| 5 Hydroxytryptamine 1F agonist | 1.0 | 169 | Mechanism of action |
| 5 Hydroxytryptamine 1F antagonist | 0.98 | 556 | Mechanism of action |
| 5 Hydroxytryptamine 2 agonist | 0.99 | 2225 | Mechanism of action |
| 5 Hydroxytryptamine 2 antagonist | 0.97 | 7461 | Mechanism of action |
| 5 Hydroxytryptamine 2A agonist | 0.99 | 451 | Mechanism of action |
| 5 Hydroxytryptamine 2A antagonist | 0.98 | 5262 | Mechanism of action |
| 5 Hydroxytryptamine 2B agonist | 0.99 | 318 | Mechanism of action |
| 5 Hydroxytryptamine 2B antagonist | 0.96 | 2340 | Mechanism of action |
| 5 Hydroxytryptamine 2C agonist | 0.99 | 1154 | Mechanism of action |
| 5 Hydroxytryptamine 2C antagonist | 0.98 | 2825 | Mechanism of action |
| 5 Hydroxytryptamine 3 agonist | 0.98 | 127 | Mechanism of action |
| 5 Hydroxytryptamine 3 antagonist | 0.99 | 2432 | Mechanism of action |
| 5 Hydroxytryptamine 3A agonist | 0.98 | 28 | Mechanism of action |
| 5 Hydroxytryptamine 3A antagonist | 0.99 | 757 | Mechanism of action |
| 5 Hydroxytryptamine 3B antagonist | 0.99 | 581 | Mechanism of action |
| 5 Hydroxytryptamine 3E antagonist | 0.86 | 13 | Mechanism of action |
| 5 Hydroxytryptamine 4 agonist | 1.0 | 718 | Mechanism of action |
| 5 Hydroxytryptamine 4 antagonist | 0.99 | 827 | Mechanism of action |
| 5 Hydroxytryptamine 5 antagonist | 0.98 | 332 | Mechanism of action |
| 5 Hydroxytryptamine 5A antagonist | 0.98 | 312 | Mechanism of action |
| 5 Hydroxytryptamine 6 agonist | 1.0 | 166 | Mechanism of action |
| 5 Hydroxytryptamine 6 antagonist | 0.99 | 2548 | Mechanism of action |
| 5 Hydroxytryptamine 7 agonist | 0.99 | 62 | Mechanism of action |
| 5 Hydroxytryptamine 7 antagonist | 0.98 | 1272 | Mechanism of action |
| 5 Hydroxytryptamine agonist | 0.98 | 6367 | Mechanism of action |
| 5 Hydroxytryptamine antagonist | 0.97 | 18747 | Mechanism of action |
| 5 Hydroxytryptamine release inhibitor | 0.86 | 38 | Mechanism of action |
| 5 Hydroxytryptamine release stimulant | 0.91 | 23 | Mechanism of action |
| 5 Hydroxytryptamine uptake inhibitor | 0.99 | 7398 | Mechanism of action |
| 5 Hydroxytryptamine uptake stimulant | 0.89 | 16 | Mechanism of action |
| 5 Lipoxygenase activating protein inhibitor | 1.0 | 2174 | Mechanism of action |
| 5-Alpha-reductase 1 inhibitor | 1.0 | 687 | Mechanism of action |
| 5-Alpha-reductase 2 inhibitor | 0.99 | 642 | Mechanism of action |
| 5-Alpha-reductase inhibitor | 0.99 | 1738 | Mechanism of action |
| 5-Lipoxygenase inhibitor | 0.97 | 3881 | Mechanism of action |
| ABCA1 expression enhancer | 0.96 | 278 | Mechanism of action |
| ADAM10 endopeptidase inhibitor | 0.99 | 152 | Mechanism of action |
| AICAR transformylase inhibitor | 0.99 | 89 | Mechanism of action |
| ALK inhibitor | 0.98 | 3579 | Mechanism of action |
| AMP-activated protein kinase stimulant | 0.97 | 786 | Mechanism of action |
| AMPA 1 receptor antagonist | 1.0 | 724 | Mechanism of action |
| AMPA 2 receptor antagonist | 0.99 | 468 | Mechanism of action |
| AMPA 3 receptor antagonist | 1.0 | 438 | Mechanism of action |
| AMPA 4 receptor antagonist | 0.99 | 245 | Mechanism of action |
| AMPA receptor agonist | 1.0 | 244 | Mechanism of action |
| AMPA receptor antagonist | 0.99 | 2030 | Mechanism of action |
| ATM kinase inhibitor | 0.99 | 463 | Mechanism of action |
| ATP citrate lysase inhibitor | 1.0 | 88 | Mechanism of action |
| ATPase (Vacuolar H+) inhibitor | 0.98 | 106 | Mechanism of action |
| ATPase inhibitor | 0.94 | 323 | Mechanism of action |
| ATR kinase inhibitor | 0.99 | 440 | Mechanism of action |
| AXL receptor tyrosine kinase inhibitor | 0.97 | 1372 | Mechanism of action |
| Abl kinase inhibitor | 0.97 | 4089 | Mechanism of action |
| Acetyl-CoA carboxylase 1 inhibitor | 1.0 | 653 | Mechanism of action |
| Acetyl-CoA carboxylase 2 inhibitor | 1.0 | 1193 | Mechanism of action |
| Acetyl-CoA carboxylase inhibitor | 0.99 | 1450 | Mechanism of action |
| Acetyl-CoA transferase 1 inhibitor | 0.99 | 1857 | Mechanism of action |
| Acetyl-CoA transferase 2 inhibitor | 0.98 | 404 | Mechanism of action |
| Acetyl-CoA transferase inhibitor | 0.99 | 3533 | Mechanism of action |
| Acetylcholine M1 receptor agonist | 0.99 | 1835 | Mechanism of action |
| Acetylcholine M1 receptor antagonist | 0.95 | 2790 | Mechanism of action |
| Acetylcholine M2 receptor agonist | 0.99 | 314 | Mechanism of action |
| Acetylcholine M2 receptor antagonist | 0.99 | 2988 | Mechanism of action |
| Acetylcholine M3 receptor agonist | 0.98 | 155 | Mechanism of action |
| Acetylcholine M3 receptor antagonist | 0.99 | 3400 | Mechanism of action |
| Acetylcholine M4 receptor agonist | 1.0 | 411 | Mechanism of action |
| Acetylcholine M4 receptor antagonist | 0.98 | 1143 | Mechanism of action |
| Acetylcholine M5 receptor agonist | 0.99 | 123 | Mechanism of action |
| Acetylcholine M5 receptor antagonist | 0.99 | 1162 | Mechanism of action |
| Acetylcholine agonist | 0.97 | 3921 | Mechanism of action |
| Acetylcholine antagonist | 0.96 | 9446 | Mechanism of action |
| Acetylcholine muscarinic agonist | 0.99 | 2284 | Mechanism of action |
| Acetylcholine muscarinic antagonist | 0.96 | 6725 | Mechanism of action |
| Acetylcholine nicotinic agonist | 0.98 | 1604 | Mechanism of action |
| Acetylcholine nicotinic antagonist | 0.98 | 2865 | Mechanism of action |
| Acetylcholine release stimulant | 0.96 | 154 | Mechanism of action |
| Acetylcholinesterase inhibitor | 0.96 | 9275 | Mechanism of action |
| Acid ceramidase inhibitor | 1.0 | 157 | Mechanism of action |
| Acid-sensing ion channel blocker | 0.99 | 98 | Mechanism of action |
| Aconitate hydratase inhibitor | 0.99 | 24 | Mechanism of action |
| Activin receptor-like kinase 2 inhibitor | 0.96 | 345 | Mechanism of action |
| Activin receptor-like kinase 4 inhibitor | 0.96 | 120 | Mechanism of action |
| Acyl-CoA dehydrogenase inhibitor | 1.0 | 19 | Mechanism of action |
| Adenine nucleotide translocase inhibitor | 0.99 | 24 | Mechanism of action |
| Adenosine A1 receptor agonist | 1.0 | 752 | Mechanism of action |
| Adenosine A1 receptor antagonist | 0.99 | 4749 | Mechanism of action |
| Adenosine A2 receptor agonist | 1.0 | 847 | Mechanism of action |
| Adenosine A2 receptor antagonist | 0.99 | 6432 | Mechanism of action |
| Adenosine A2a receptor agonist | 1.0 | 517 | Mechanism of action |
| Adenosine A2a receptor antagonist | 0.99 | 4912 | Mechanism of action |
| Adenosine A2b receptor agonist | 0.99 | 213 | Mechanism of action |
| Adenosine A2b receptor antagonist | 0.99 | 1999 | Mechanism of action |
| Adenosine A3 receptor agonist | 1.0 | 345 | Mechanism of action |
| Adenosine A3 receptor antagonist | 0.97 | 2313 | Mechanism of action |
| Adenosine deaminase inhibitor | 0.99 | 309 | Mechanism of action |
| Adenosine kinase inhibitor | 1.0 | 761 | Mechanism of action |
| Adenosine uptake inhibitor | 0.99 | 69 | Mechanism of action |
| Adenylate cyclase inhibitor | 0.96 | 313 | Mechanism of action |
| Adenylate cyclase stimulant | 0.95 | 96 | Mechanism of action |
| Adenylate kinase inhibitor | 0.95 | 28 | Mechanism of action |
| Adrenaline agonist | 0.98 | 7304 | Mechanism of action |
| Adrenaline antagonist | 0.97 | 9607 | Mechanism of action |
| Adrenaline uptake inhibitor | 0.98 | 4131 | Mechanism of action |
| Aggrecanase 1 inhibitor | 0.99 | 252 | Mechanism of action |
| Aggrecanase 2 inhibitor | 1.0 | 463 | Mechanism of action |
| Alcohol dehydrogenase inhibitor | 0.98 | 329 | Mechanism of action |
| Alcohol oxidase inhibitor | 1.0 | 26 | Mechanism of action |
| Aldehyde dehydrogenase inhibitor | 0.96 | 226 | Mechanism of action |
| Aldehyde oxidase inhibitor | 0.93 | 38 | Mechanism of action |
| Aldose reductase inhibitor | 0.99 | 2728 | Mechanism of action |
| Aldosterone antagonist | 0.99 | 229 | Mechanism of action |
| Alkaline phosphatase inhibitor | 0.96 | 636 | Mechanism of action |
| Alkylator | 0.96 | 1095 | Mechanism of action |
| Alpha 1 adrenoreceptor agonist | 0.99 | 1069 | Mechanism of action |
| Alpha 1 adrenoreceptor antagonist | 0.98 | 5762 | Mechanism of action |
| Alpha 1L adrenoreceptor agonist | 1.0 | 9 | Mechanism of action |
| Alpha 1L adrenoreceptor antagonist | 1.0 | 16 | Mechanism of action |
| Alpha 1a adrenoreceptor agonist | 1.0 | 262 | Mechanism of action |
| Alpha 1a adrenoreceptor antagonist | 0.98 | 4517 | Mechanism of action |
| Alpha 1b adrenoreceptor agonist | 0.98 | 60 | Mechanism of action |
| Alpha 1b adrenoreceptor antagonist | 0.98 | 2132 | Mechanism of action |
| Alpha 1d adrenoreceptor agonist | 1.0 | 49 | Mechanism of action |
| Alpha 1d adrenoreceptor antagonist | 0.99 | 2127 | Mechanism of action |
| Alpha 2 adrenoreceptor agonist | 0.99 | 1092 | Mechanism of action |
| Alpha 2 adrenoreceptor antagonist | 0.97 | 2759 | Mechanism of action |
| Alpha 2a adrenoreceptor agonist | 1.0 | 103 | Mechanism of action |
| Alpha 2a adrenoreceptor antagonist | 0.98 | 1698 | Mechanism of action |
| Alpha 2b adrenoreceptor agonist | 1.0 | 152 | Mechanism of action |
| Alpha 2b adrenoreceptor antagonist | 0.96 | 734 | Mechanism of action |
| Alpha 2c adrenoreceptor agonist | 1.0 | 246 | Mechanism of action |
| Alpha 2c adrenoreceptor antagonist | 0.97 | 912 | Mechanism of action |
| Alpha 2d adrenoreceptor agonist | 1.0 | 75 | Mechanism of action |
| Alpha 2d adrenoreceptor antagonist | 0.97 | 116 | Mechanism of action |
| Alpha adrenoreceptor agonist | 0.98 | 1935 | Mechanism of action |
| Alpha adrenoreceptor antagonist | 0.97 | 7610 | Mechanism of action |
| Alpha tubulin antagonist | 0.99 | 392 | Mechanism of action |
| Alpha-N-acetylglucosaminidase inhibitor | 0.99 | 5 | Mechanism of action |
| Alpha-mannosidase inhibitor | 0.99 | 97 | Mechanism of action |
| Amidase inhibitor | 0.98 | 921 | Mechanism of action |
| Aminoacyl-tRNA synthetase inhibitor | 0.97 | 775 | Mechanism of action |
| Aminopeptidase A inhibitor | 1.0 | 81 | Mechanism of action |
| Aminopeptidase B inhibitor | 0.97 | 66 | Mechanism of action |
| Aminopeptidase I inhibitor | 0.99 | 27 | Mechanism of action |
| Aminopeptidase N inhibitor | 0.99 | 820 | Mechanism of action |
| Aminopeptidase P inhibitor | 1.0 | 10 | Mechanism of action |
| Aminopeptidase microsomal inhibitor | 0.98 | 859 | Mechanism of action |
| Amylase inhibitor | 0.95 | 156 | Mechanism of action |
| Amyloid beta aggregation inhibitor | 0.94 | 1139 | Mechanism of action |
| Amyloid beta precursor protein antagonist | 0.94 | 426 | Mechanism of action |
| Anabolic | 0.97 | 185 | Mechanism of action |
| Analgesic | 0.86 | 33470 | Mechanism of action |
| Analgesic, opioid | 0.98 | 3646 | Mechanism of action |
| Androgen agonist | 0.98 | 822 | Mechanism of action |
| Androgen antagonist | 0.98 | 2986 | Mechanism of action |
| Anesthetic general | 0.95 | 226 | Mechanism of action |
| Anesthetic local | 0.97 | 620 | Mechanism of action |
| Angiogenesis inhibitor | 0.89 | 9144 | Mechanism of action |
| Angiogenesis stimulant | 0.94 | 142 | Mechanism of action |
| Angiotensin AT1 receptor antagonist | 0.99 | 6176 | Mechanism of action |
| Angiotensin AT1A receptor antagonist | 1.0 | 1624 | Mechanism of action |
| Angiotensin AT1B receptor antagonist | 1.0 | 1413 | Mechanism of action |
| Angiotensin AT2 receptor agonist | 1.0 | 83 | Mechanism of action |
| Angiotensin AT2 receptor antagonist | 1.0 | 1575 | Mechanism of action |
| Angiotensin II receptor antagonist | 0.99 | 6810 | Mechanism of action |
| Angiotensin-converting enzyme 2 inhibitor | 1.0 | 186 | Mechanism of action |
| Angiotensin-converting enzyme inhibitor | 0.99 | 2189 | Mechanism of action |
| Antiadrenergic | 0.97 | 9678 | Mechanism of action |
| Antiamyloidogenic | 0.93 | 3286 | Mechanism of action |
| Antibacterial | 0.87 | 47866 | Mechanism of action |
| Antibiotic Aminoglycoside-like | 0.99 | 93 | Mechanism of action |
| Antibiotic Anthracycline-like | 1.0 | 75 | Mechanism of action |
| Antibiotic Macrolide-like | 1.0 | 1008 | Mechanism of action |
| Antibiotic Penicillin-like | 1.0 | 174 | Mechanism of action |
| Antibiotic Rifamycin-like | 1.0 | 65 | Mechanism of action |
| Antibiotic Tetracycline-like | 0.99 | 35 | Mechanism of action |
| Anticoagulant | 0.95 | 9613 | Mechanism of action |
| Anticonvulsant | 0.94 | 4690 | Mechanism of action |
| Antidiuretic hormone agonist | 0.99 | 553 | Mechanism of action |
| Antidiuretic hormone antagonist | 0.99 | 2482 | Mechanism of action |
| Antihistaminic | 0.97 | 8923 | Mechanism of action |
| Antiinflammatory | 0.82 | 38424 | Mechanism of action |
| Antimetabolite | 0.99 | 946 | Mechanism of action |
| Antimitotic | 0.93 | 7085 | Mechanism of action |
| Antineoplastic alkaloid | 0.97 | 99 | Mechanism of action |
| Antineoplastic antibiotic | 0.98 | 2909 | Mechanism of action |
| Antiobesity | 0.88 | 21578 | Mechanism of action |
| Antioxidant | 0.92 | 4992 | Mechanism of action |
| Antipruritic | 0.94 | 1318 | Mechanism of action |
| Antithrombotic | 0.89 | 681 | Mechanism of action |
| Apolipoprotein B inhibitor | 1.0 | 225 | Mechanism of action |
| Apolipoprotein B-100 inhibitor | 1.0 | 326 | Mechanism of action |
| Apoptosis agonist | 0.84 | 11822 | Mechanism of action |
| Apoptosis antagonist | 0.88 | 1018 | Mechanism of action |
| Arachidonic acid antagonist | 0.95 | 99 | Mechanism of action |
| Arginase inhibitor | 1.0 | 235 | Mechanism of action |
| Argininosuccinate synthase inhibitor | 0.99 | 22 | Mechanism of action |
| Aromatase inhibitor | 0.99 | 2494 | Mechanism of action |
| Aryl hydrocarbon receptor agonist | 0.94 | 172 | Mechanism of action |
| Aryl hydrocarbon receptor antagonist | 0.98 | 235 | Mechanism of action |
| Aurora-A kinase inhibitor | 0.97 | 6629 | Mechanism of action |
| Aurora-B kinase inhibitor | 0.97 | 4401 | Mechanism of action |
| Aurora-C kinase inhibitor | 0.95 | 234 | Mechanism of action |
| Autotaxin inhibitor | 0.98 | 672 | Mechanism of action |
| Baculoviral IAP repeat-containing protein 2 inhibitor | 1.0 | 547 | Mechanism of action |
| Baculoviral IAP repeat-containing protein 3 inhibitor | 0.99 | 248 | Mechanism of action |
| Baculoviral IAP repeat-containing protein 4 inhibitor | 0.99 | 214 | Mechanism of action |
| Baculoviral IAP repeat-containing protein inhibitor | 0.99 | 1275 | Mechanism of action |
| Bcl-xL inhibitor | 0.98 | 254 | Mechanism of action |
| Bcl2 antagonist | 0.98 | 2032 | Mechanism of action |
| Bcr-Abl kinase inhibitor | 0.98 | 620 | Mechanism of action |
| Benzodiazepine agonist | 0.98 | 482 | Mechanism of action |
| Benzodiazepine antagonist | 0.99 | 669 | Mechanism of action |
| Benzodiazepine inverse agonist | 0.99 | 69 | Mechanism of action |
| Benzodiazepine receptor peripheral-type antagonist | 0.99 | 605 | Mechanism of action |
| Beta 1 adrenoreceptor agonist | 1.0 | 882 | Mechanism of action |
| Beta 1 adrenoreceptor antagonist | 0.99 | 1071 | Mechanism of action |
| Beta 2 adrenoreceptor agonist | 0.98 | 2840 | Mechanism of action |
| Beta 2 adrenoreceptor antagonist | 0.99 | 1143 | Mechanism of action |
| Beta 3 adrenoreceptor agonist | 1.0 | 2664 | Mechanism of action |
| Beta 3 adrenoreceptor antagonist | 0.98 | 449 | Mechanism of action |
| Beta adrenoreceptor agonist | 0.99 | 5416 | Mechanism of action |
| Beta adrenoreceptor antagonist | 0.98 | 2194 | Mechanism of action |
| Beta amyloid protein antagonist | 0.96 | 1242 | Mechanism of action |
| Beta glucuronidase inhibitor | 0.97 | 286 | Mechanism of action |
| Beta lactamase inhibitor | 0.88 | 33735 | Mechanism of action |
| Beta tubulin antagonist | 0.99 | 862 | Mechanism of action |
| Biliverdin reductase inhibitor | 1.0 | 13 | Mechanism of action |
| Bombesin 1 receptor agonist | 1.0 | 7 | Mechanism of action |
| Bombesin 1 receptor antagonist | 1.0 | 69 | Mechanism of action |
| Bombesin 2 receptor antagonist | 0.98 | 74 | Mechanism of action |
| Bombesin 3 receptor agonist | 1.0 | 376 | Mechanism of action |
| Bombesin 3 receptor antagonist | 0.99 | 51 | Mechanism of action |
| Bombesin agonist | 1.0 | 386 | Mechanism of action |
| Bombesin antagonist | 0.99 | 303 | Mechanism of action |
| Bone formation stimulant | 0.96 | 1259 | Mechanism of action |
| Bone morphogenic protein 1 inhibitor | 1.0 | 766 | Mechanism of action |
| Botulinum neurotoxin type A inhibitor | 0.98 | 286 | Mechanism of action |
| Bradykinin B1 receptor agonist | 1.0 | 8 | Mechanism of action |
| Bradykinin B1 receptor antagonist | 1.0 | 1661 | Mechanism of action |
| Bradykinin B2 receptor agonist | 1.0 | 14 | Mechanism of action |
| Bradykinin B2 receptor antagonist | 1.0 | 822 | Mechanism of action |
| Bradykinin antagonist | 0.99 | 2584 | Mechanism of action |
| Breast cancer-resistant protein inhibitor | 0.97 | 224 | Mechanism of action |
| Bromodomain-containing protein 2 inhibitor | 0.97 | 435 | Mechanism of action |
| Bromodomain-containing protein 3 inhibitor | 0.99 | 382 | Mechanism of action |
| Bromodomain-containing protein 4 inhibitor | 0.99 | 3085 | Mechanism of action |
| Bronchodilator | 0.97 | 2993 | Mechanism of action |
| Bruton tyrosine kinase inhibitor | 0.99 | 4463 | Mechanism of action |
| Butyrylcholinesterase inhibitor | 0.97 | 4816 | Mechanism of action |
| CC chemokine 1 receptor antagonist | 1.0 | 885 | Mechanism of action |
| CC chemokine 10 receptor antagonist | 0.99 | 76 | Mechanism of action |
| CC chemokine 2 receptor antagonist | 0.99 | 1818 | Mechanism of action |
| CC chemokine 3 receptor antagonist | 0.99 | 1290 | Mechanism of action |
| CC chemokine 4 receptor antagonist | 0.99 | 430 | Mechanism of action |
| CC chemokine 5 receptor agonist | 0.96 | 52 | Mechanism of action |
| CC chemokine 5 receptor antagonist | 0.99 | 2152 | Mechanism of action |
| CC chemokine 6 receptor antagonist | 0.91 | 47 | Mechanism of action |
| CC chemokine 8 receptor antagonist | 0.99 | 190 | Mechanism of action |
| CC chemokine 9 receptor antagonist | 1.0 | 403 | Mechanism of action |
| CC chemokine receptor 2B antagonist | 0.99 | 94 | Mechanism of action |
| CC chemokine receptor antagonist | 0.98 | 8174 | Mechanism of action |
| CD45 antagonist | 0.98 | 131 | Mechanism of action |
| CD80 antagonist | 0.99 | 120 | Mechanism of action |
| CDC-like kinase 1 inhibitor | 0.96 | 592 | Mechanism of action |
| CDC-like kinase 2 inhibitor | 0.95 | 662 | Mechanism of action |
| CDC-like kinase 3 inhibitor | 0.96 | 131 | Mechanism of action |
| CDC-like kinase 4 inhibitor | 0.95 | 1130 | Mechanism of action |
| CDC25A inhibitor | 0.98 | 206 | Mechanism of action |
| CDC25B inhibitor | 0.98 | 368 | Mechanism of action |
| CDC7 inhibitor | 0.98 | 792 | Mechanism of action |
| CDK1/cyclin B inhibitor | 0.99 | 3860 | Mechanism of action |
| CDK1/cyclin B1 inhibitor | 0.98 | 603 | Mechanism of action |
| CDK2/cyclin A inhibitor | 0.97 | 4374 | Mechanism of action |
| CDK2/cyclin A3 inhibitor | 1.0 | 318 | Mechanism of action |
| CDK2/cyclin E inhibitor | 0.99 | 4129 | Mechanism of action |
| CDK2/cyclin E2 inhibitor | 0.98 | 727 | Mechanism of action |
| CDK3/cyclin E inhibitor | 0.96 | 118 | Mechanism of action |
| CDK4/cyclin D inhibitor | 0.99 | 5089 | Mechanism of action |
| CDK4/cyclin D1 inhibitor | 0.99 | 3691 | Mechanism of action |
| CDK4/cyclin D3 inhibitor | 0.99 | 737 | Mechanism of action |
| CDK5/p25 inhibitor | 0.99 | 1226 | Mechanism of action |
| CDK6/cyclin D3 inhibitor | 0.99 | 1035 | Mechanism of action |
| CDK7/cyclin H inhibitor | 0.99 | 428 | Mechanism of action |
| CDK9/cyclin T1 inhibitor | 0.99 | 1292 | Mechanism of action |
| CF transmembrane conductance regulator agonist | 0.95 | 50 | Mechanism of action |
| CF transmembrane conductance regulator antagonist | 0.99 | 394 | Mechanism of action |
| CXC chemokine 1 receptor antagonist | 0.98 | 285 | Mechanism of action |
| CXC chemokine 2 receptor antagonist | 1.0 | 899 | Mechanism of action |
| CXC chemokine 3 receptor antagonist | 1.0 | 976 | Mechanism of action |
| CXC chemokine 4 receptor antagonist | 0.98 | 816 | Mechanism of action |
| CXC chemokine 5 receptor antagonist | 0.99 | 376 | Mechanism of action |
| CXC chemokine receptor agonist | 1.0 | 1006 | Mechanism of action |
| CXC chemokine receptor antagonist | 0.98 | 4026 | Mechanism of action |
| CYP24 inhibitor | 1.0 | 68 | Mechanism of action |
| CYP2A6 inhibitor | 0.98 | 234 | Mechanism of action |
| Ca(v)2.2 blocker | 0.97 | 616 | Mechanism of action |
| Ca2+-transporting ATPase inhibitor | 0.85 | 13 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.92 | 106 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.9 | 161 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.94 | 268 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.96 | 435 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.95 | 288 | Mechanism of action |
| Ca2+/calmodulin-dependent kinase IV inhibitor | 0.87 | 36 | Mechanism of action |
| Ca2+/calmodulin-dependent protein kinase inhibitor | 0.93 | 860 | Mechanism of action |
| Calcineurin inhibitor | 1.0 | 21 | Mechanism of action |
| Calcitonin gene-related peptide 1 receptor antagonist | 1.0 | 549 | Mechanism of action |
| Calcitonin gene-related peptide antagonist | 1.0 | 1270 | Mechanism of action |
| Calcitonin receptor agonist | 0.99 | 86 | Mechanism of action |
| Calcium antagonist | 0.98 | 139 | Mechanism of action |
| Calcium channel (voltage-sensitive) blocker | 0.96 | 6466 | Mechanism of action |
| Calcium channel L-type activator | 0.9 | 10 | Mechanism of action |
| Calcium channel L-type blocker | 0.98 | 2577 | Mechanism of action |
| Calcium channel N-type blocker | 0.96 | 2946 | Mechanism of action |
| Calcium channel P-type blocker | 0.96 | 94 | Mechanism of action |
| Calcium channel T-type blocker | 0.99 | 1738 | Mechanism of action |
| Calcium channel activator | 0.88 | 86 | Mechanism of action |
| Calcium channel blocker | 0.95 | 8910 | Mechanism of action |
| Calcium release-activated channel blocker | 0.99 | 923 | Mechanism of action |
| Calcium-dependent phospholipase A2 inhibitor | 1.0 | 116 | Mechanism of action |
| Calcium-independent phospholipase A2 inhibitor | 0.98 | 67 | Mechanism of action |
| Calcium-sensing receptor agonist | 1.0 | 309 | Mechanism of action |
| Calcium-sensing receptor antagonist | 1.0 | 493 | Mechanism of action |
| Calpain 1 inhibitor | 1.0 | 977 | Mechanism of action |
| Calpain 2 inhibitor | 0.9 | 787 | Mechanism of action |
| Calpain inhibitor | 0.93 | 1618 | Mechanism of action |
| Cannabinoid CB1 receptor agonist | 0.99 | 2673 | Mechanism of action |
| Cannabinoid CB1 receptor antagonist | 0.98 | 3868 | Mechanism of action |
| Cannabinoid CB2 receptor agonist | 0.99 | 3873 | Mechanism of action |
| Cannabinoid CB2 receptor antagonist | 0.99 | 2085 | Mechanism of action |
| Cannabinoid receptor agonist | 0.99 | 5721 | Mechanism of action |
| Cannabinoid receptor antagonist | 0.98 | 4947 | Mechanism of action |
| Carbonic anhydrase I inhibitor | 0.99 | 5663 | Mechanism of action |
| Carbonic anhydrase I stimulant | 1.0 | 88 | Mechanism of action |
| Carbonic anhydrase II inhibitor | 0.99 | 6816 | Mechanism of action |
| Carbonic anhydrase II stimulant | 0.98 | 92 | Mechanism of action |
| Carbonic anhydrase III inhibitor | 0.97 | 127 | Mechanism of action |
| Carbonic anhydrase IV inhibitor | 0.99 | 2080 | Mechanism of action |
| Carbonic anhydrase IV stimulant | 1.0 | 65 | Mechanism of action |
| Carbonic anhydrase IX inhibitor | 0.99 | 4617 | Mechanism of action |
| Carbonic anhydrase V inhibitor | 0.98 | 441 | Mechanism of action |
| Carbonic anhydrase VA inhibitor | 0.98 | 406 | Mechanism of action |
| Carbonic anhydrase VB inhibitor | 0.99 | 296 | Mechanism of action |
| Carbonic anhydrase VI inhibitor | 0.97 | 202 | Mechanism of action |
| Carbonic anhydrase VII inhibitor | 0.99 | 924 | Mechanism of action |
| Carbonic anhydrase VIII inhibitor | 1.0 | 14 | Mechanism of action |
| Carbonic anhydrase X inhibitor | 1.0 | 14 | Mechanism of action |
| Carbonic anhydrase XI inhibitor | 1.0 | 27 | Mechanism of action |
| Carbonic anhydrase XII inhibitor | 0.99 | 3527 | Mechanism of action |
| Carbonic anhydrase XIII inhibitor | 0.98 | 200 | Mechanism of action |
| Carbonic anhydrase XIV inhibitor | 0.99 | 545 | Mechanism of action |
| Carbonic anhydrase XV inhibitor | 0.96 | 87 | Mechanism of action |
| Carbonic anhydrase inhibitor | 0.99 | 8238 | Mechanism of action |
| Carbonic anhydrase stimulant | 0.99 | 120 | Mechanism of action |
| Carboxypeptidase B inhibitor | 0.99 | 339 | Mechanism of action |
| Cardiotonic | 0.92 | 9347 | Mechanism of action |
| Carnitine palmitoyltransferase 1 inhibitor | 0.99 | 566 | Mechanism of action |
| Carnitine palmitoyltransferase 1A inhibitor | 1.0 | 529 | Mechanism of action |
| Carnitine palmitoyltransferase 1B inhibitor | 0.99 | 176 | Mechanism of action |
| Carnitine palmitoyltransferase inhibitor | 0.99 | 579 | Mechanism of action |
| Caspase 2 inhibitor | 1.0 | 44 | Mechanism of action |
| Caspase 3 inhibitor | 0.96 | 1412 | Mechanism of action |
| Caspase 3 stimulant | 0.88 | 359 | Mechanism of action |
| Caspase 6 inhibitor | 0.99 | 246 | Mechanism of action |
| Caspase 7 inhibitor | 0.97 | 1023 | Mechanism of action |
| Caspase 8 inhibitor | 0.99 | 398 | Mechanism of action |
| Caspase 9 inhibitor | 0.98 | 63 | Mechanism of action |
| Caspase 9 stimulant | 0.83 | 95 | Mechanism of action |
| Catalase inhibitor | 0.99 | 85 | Mechanism of action |
| Catenin beta inhibitor | 0.92 | 151 | Mechanism of action |
| Cathepsin B inhibitor | 0.98 | 1525 | Mechanism of action |
| Cathepsin D inhibitor | 0.98 | 1444 | Mechanism of action |
| Cathepsin E inhibitor | 0.98 | 106 | Mechanism of action |
| Cathepsin F inhibitor | 0.99 | 63 | Mechanism of action |
| Cathepsin G inhibitor | 0.98 | 200 | Mechanism of action |
| Cathepsin H inhibitor | 0.96 | 88 | Mechanism of action |
| Cathepsin K inhibitor | 0.99 | 2589 | Mechanism of action |
| Cathepsin L inhibitor | 0.99 | 1963 | Mechanism of action |
| Cathepsin L1 inhibitor | 0.99 | 1405 | Mechanism of action |
| Cathepsin L2 inhibitor | 1.0 | 142 | Mechanism of action |
| Cathepsin S inhibitor | 1.0 | 2576 | Mechanism of action |
| Cell adhesion inhibitor | 0.96 | 1160 | Mechanism of action |
| Cell adhesion molecule inhibitor | 0.97 | 685 | Mechanism of action |
| Cell wall synthesis inhibitor | 0.95 | 1064 | Mechanism of action |
| Ceramide glucosyltransferase inhibitor | 0.99 | 174 | Mechanism of action |
| Check point kinase 1 inhibitor | 0.98 | 3388 | Mechanism of action |
| Check point kinase 2 inhibitor | 0.97 | 927 | Mechanism of action |
| Chelator | 0.96 | 799 | Mechanism of action |
| Chemokine receptor agonist | 0.99 | 1134 | Mechanism of action |
| Chemokine receptor antagonist | 0.97 | 11844 | Mechanism of action |
| Cholecystokinin A agonist | 1.0 | 308 | Mechanism of action |
| Cholecystokinin A antagonist | 0.99 | 1856 | Mechanism of action |
| Cholecystokinin B agonist | 0.99 | 67 | Mechanism of action |
| Cholecystokinin B antagonist | 1.0 | 2153 | Mechanism of action |
| Cholecystokinin agonist | 1.0 | 350 | Mechanism of action |
| Cholecystokinin antagonist | 0.99 | 2934 | Mechanism of action |
| Cholesterol antagonist | 0.9 | 127 | Mechanism of action |
| Cholesterol ester transfer protein antagonist | 0.99 | 1354 | Mechanism of action |
| Cholesterol esterase inhibitor | 0.99 | 626 | Mechanism of action |
| Cholesterol synthesis inhibitor | 0.97 | 151 | Mechanism of action |
| Cholinergic | 0.95 | 13487 | Mechanism of action |
| Cholinergic antagonist | 0.96 | 9662 | Mechanism of action |
| Chymotrypsin inhibitor | 0.97 | 508 | Mechanism of action |
| Clk dual-specificity kinase inhibitor | 0.95 | 1640 | Mechanism of action |
| Collagenase 3 inhibitor | 0.98 | 3266 | Mechanism of action |
| Collagenase inhibitor | 0.99 | 1098 | Mechanism of action |
| Complement C3a chemotactic receptor antagonist | 1.0 | 172 | Mechanism of action |
| Complement C5a chemotactic receptor antagonist | 1.0 | 828 | Mechanism of action |
| Complement factor 1 inhibitor | 0.99 | 168 | Mechanism of action |
| Complement factor 1r inhibitor | 0.99 | 49 | Mechanism of action |
| Complement factor 1s inhibitor | 0.99 | 122 | Mechanism of action |
| Complement factor D inhibitor | 1.0 | 1132 | Mechanism of action |
| Corticosteroid-like | 1.0 | 128 | Mechanism of action |
| Corticotropin releasing factor 1 receptor antagonist | 1.0 | 1600 | Mechanism of action |
| Corticotropin releasing factor 2 receptor antagonist | 0.98 | 66 | Mechanism of action |
| Corticotropin releasing factor antagonist | 1.0 | 681 | Mechanism of action |
| Creatine kinase inhibitor | 0.98 | 34 | Mechanism of action |
| Cyclic AMP phosphodiesterase inhibitor | 0.92 | 268 | Mechanism of action |
| Cyclin A inhibitor | 0.98 | 1722 | Mechanism of action |
| Cyclin A1 inhibitor | 0.99 | 522 | Mechanism of action |
| Cyclin A2 inhibitor | 0.98 | 1547 | Mechanism of action |
| Cyclin B inhibitor | 0.99 | 450 | Mechanism of action |
| Cyclin B1 inhibitor | 0.99 | 400 | Mechanism of action |
| Cyclin B2 inhibitor | 0.99 | 390 | Mechanism of action |
| Cyclin B3 inhibitor | 0.98 | 192 | Mechanism of action |
| Cyclin D1 inhibitor | 0.98 | 217 | Mechanism of action |
| Cyclin D2 inhibitor | 0.99 | 140 | Mechanism of action |
| Cyclin D3 inhibitor | 0.99 | 418 | Mechanism of action |
| Cyclin E inhibitor | 0.99 | 1579 | Mechanism of action |
| Cyclin E1 inhibitor | 0.99 | 1421 | Mechanism of action |
| Cyclin E2 inhibitor | 1.0 | 750 | Mechanism of action |
| Cyclin H inhibitor | 0.98 | 149 | Mechanism of action |
| Cyclin T1 inhibitor | 1.0 | 334 | Mechanism of action |
| Cyclin-dependent kinase 1 inhibitor | 0.97 | 2593 | Mechanism of action |
| Cyclin-dependent kinase 2 inhibitor | 0.97 | 4127 | Mechanism of action |
| Cyclin-dependent kinase 3 inhibitor | 0.93 | 29 | Mechanism of action |
| Cyclin-dependent kinase 4 inhibitor | 0.98 | 2505 | Mechanism of action |
| Cyclin-dependent kinase 5 inhibitor | 0.97 | 1945 | Mechanism of action |
| Cyclin-dependent kinase 6 inhibitor | 0.99 | 568 | Mechanism of action |
| Cyclin-dependent kinase 7 inhibitor | 0.96 | 483 | Mechanism of action |
| Cyclin-dependent kinase 8 inhibitor | 0.95 | 617 | Mechanism of action |
| Cyclin-dependent kinase 9 inhibitor | 0.97 | 1040 | Mechanism of action |
| Cyclin-dependent kinase inhibitor | 0.96 | 9943 | Mechanism of action |
| Cyclooxygenase 1 inhibitor | 0.96 | 3250 | Mechanism of action |
| Cyclooxygenase 2 inhibitor | 0.96 | 6671 | Mechanism of action |
| Cyclooxygenase 3 inhibitor | 0.96 | 102 | Mechanism of action |
| Cyclooxygenase inhibitor | 0.95 | 8791 | Mechanism of action |
| Cyclophilin A inhibitor | 1.0 | 173 | Mechanism of action |
| Cyclophilin D inhibitor | 0.85 | 42620 | Mechanism of action |
| Cystathionine beta-synthase inhibitor | 0.98 | 34 | Mechanism of action |
| Cytidine deaminase inhibitor | 0.96 | 682 | Mechanism of action |
| Cytokine production inhibitor | 0.95 | 824 | Mechanism of action |
| Cytokine production stimulant | 0.99 | 278 | Mechanism of action |
| D-Ala-D-Ala ligase inhibitor | 0.96 | 34 | Mechanism of action |
| DNA damaging | 0.92 | 1247 | Mechanism of action |
| DNA directed DNA polymerase inhibitor | 0.86 | 6235 | Mechanism of action |
| DNA directed RNA polymerase inhibitor | 0.96 | 3137 | Mechanism of action |
| DNA gyrase inhibitor | 0.98 | 1794 | Mechanism of action |
| DNA gyrase subunit A inhibitor | 0.99 | 121 | Mechanism of action |
| DNA gyrase subunit B inhibitor | 0.99 | 1011 | Mechanism of action |
| DNA helicase inhibitor | 0.98 | 41 | Mechanism of action |
| DNA intercalator | 0.96 | 1281 | Mechanism of action |
| DNA methylase inhibitor | 0.94 | 470 | Mechanism of action |
| DNA methyltransferase I inhibitor | 0.94 | 387 | Mechanism of action |
| DNA polymerase I inhibitor | 0.97 | 70 | Mechanism of action |
| DNA polymerase III inhibitor | 0.99 | 250 | Mechanism of action |
| DNA polymerase III polC-type inhibitor | 1.0 | 135 | Mechanism of action |
| DNA polymerase III subunit alpha inhibitor | 1.0 | 40 | Mechanism of action |
| DNA polymerase beta inhibitor | 0.86 | 5376 | Mechanism of action |
| DNA repair enzyme inhibitor | 0.95 | 350 | Mechanism of action |
| DNA synthesis inhibitor | 0.92 | 311 | Mechanism of action |
| DNA topoisomerase III inhibitor | 1.0 | 32 | Mechanism of action |
| DNA topoisomerase IV inhibitor | 0.99 | 206 | Mechanism of action |
| DNA-dependent protein kinase inhibitor | 0.99 | 1217 | Mechanism of action |
| DOPA decarboxylase inhibitor | 0.97 | 26 | Mechanism of action |
| Death-associated protein kinase 1 inhibitor | 0.94 | 47 | Mechanism of action |
| Death-associated protein kinase 2 inhibitor | 0.95 | 26 | Mechanism of action |
| Death-associated protein kinase 3 inhibitor | 0.94 | 360 | Mechanism of action |
| Delayed rectifier potassium channel activator | 0.99 | 516 | Mechanism of action |
| Delayed rectifier potassium channel blocker | 1.0 | 71 | Mechanism of action |
| Diacylglycerol O-acyltransferase 1 inhibitor | 1.0 | 1549 | Mechanism of action |
| Diacylglycerol O-acyltransferase inhibitor | 0.99 | 1696 | Mechanism of action |
| Diamine oxidase inhibitor | 1.0 | 261 | Mechanism of action |
| Dihydrofolate reductase inhibitor | 0.99 | 3172 | Mechanism of action |
| Dihydroorotase inhibitor | 0.99 | 69 | Mechanism of action |
| Dihydroorotate dehydrogenase inhibitor | 0.99 | 1199 | Mechanism of action |
| Dihydroorotate oxidase inhibitor | 0.98 | 85 | Mechanism of action |
| Dihydropteroate synthase inhibitor | 1.0 | 91 | Mechanism of action |
| Dipeptidyl peptidase I inhibitor | 1.0 | 824 | Mechanism of action |
| Dipeptidyl peptidase II inhibitor | 0.99 | 594 | Mechanism of action |
| Dipeptidyl peptidase IV inhibitor | 0.99 | 5300 | Mechanism of action |
| Dipeptidyl peptidase IX inhibitor | 1.0 | 427 | Mechanism of action |
| Dipeptidyl peptidase VIII inhibitor | 1.0 | 589 | Mechanism of action |
| Dipeptidyl peptidase inhibitor | 0.98 | 6309 | Mechanism of action |
| Diuretic | 0.95 | 1491 | Mechanism of action |
| Dopamine D1 agonist | 1.0 | 591 | Mechanism of action |
| Dopamine D1 antagonist | 0.98 | 1613 | Mechanism of action |
| Dopamine D2 agonist | 0.99 | 1040 | Mechanism of action |
| Dopamine D2 antagonist | 0.98 | 8375 | Mechanism of action |
| Dopamine D3 agonist | 0.99 | 538 | Mechanism of action |
| Dopamine D3 antagonist | 0.98 | 3789 | Mechanism of action |
| Dopamine D4 agonist | 0.99 | 715 | Mechanism of action |
| Dopamine D4 antagonist | 0.99 | 2387 | Mechanism of action |
| Dopamine D5 agonist | 1.0 | 10 | Mechanism of action |
| Dopamine D5 antagonist | 0.99 | 334 | Mechanism of action |
| Dopamine agonist | 0.98 | 2896 | Mechanism of action |
| Dopamine antagonist | 0.98 | 10756 | Mechanism of action |
| Dopamine autoreceptor agonist | 1.0 | 185 | Mechanism of action |
| Dopamine beta hydroxylase inhibitor | 0.99 | 217 | Mechanism of action |
| Dopamine transporter inhibitor | 0.99 | 2331 | Mechanism of action |
| Dopamine uptake inhibitor | 0.99 | 3932 | Mechanism of action |
| Dual specificity phosphatase 3 inhibitor | 0.95 | 385 | Mechanism of action |
| Dual specificity phosphatase inhibitor | 0.94 | 491 | Mechanism of action |
| Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.94 | 2371 | Mechanism of action |
| Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.96 | 507 | Mechanism of action |
| Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.96 | 91 | Mechanism of action |
| Dyrk kinase inhibitor | 0.94 | 2616 | Mechanism of action |
| Egl nine homolog 1 inhibitor | 1.0 | 593 | Mechanism of action |
| Egl nine homolog 2 inhibitor | 1.0 | 181 | Mechanism of action |
| Egl nine homolog 3 inhibitor | 1.0 | 154 | Mechanism of action |
| Elastase 1 inhibitor | 0.99 | 64 | Mechanism of action |
| Elastase 2 inhibitor | 1.0 | 100 | Mechanism of action |
| Elastase 2A inhibitor | 1.0 | 100 | Mechanism of action |
| Elastase 2B inhibitor | 1.0 | 14 | Mechanism of action |
| Elastase 3A inhibitor | 1.0 | 14 | Mechanism of action |
| Elastase 3B inhibitor | 1.0 | 14 | Mechanism of action |
| Elastase inhibitor | 0.99 | 2756 | Mechanism of action |
| Electrolyte absorption antagonist | 0.97 | 72 | Mechanism of action |
| Electron transport complex I inhibitor | 0.96 | 139 | Mechanism of action |
| Endothelial nitric-oxide synthase inhibitor | 1.0 | 565 | Mechanism of action |
| Endothelin A receptor antagonist | 1.0 | 2627 | Mechanism of action |
| Endothelin B receptor antagonist | 1.0 | 1614 | Mechanism of action |
| Endothelin receptor antagonist | 1.0 | 3398 | Mechanism of action |
| Endothelin-converting enzyme inhibitor | 0.99 | 624 | Mechanism of action |
| Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.98 | 366 | Mechanism of action |
| EphA2 antagonist | 0.97 | 756 | Mechanism of action |
| EphB2 antagonist | 0.95 | 78 | Mechanism of action |
| EphB4 antagonist | 0.98 | 1604 | Mechanism of action |
| Ephrin antagonist | 0.97 | 2206 | Mechanism of action |
| Epidermal growth factor antagonist | 0.97 | 6358 | Mechanism of action |
| Epidermal growth factor receptor kinase inhibitor | 0.96 | 11157 | Mechanism of action |
| Epithelial sodium channel blocker | 0.98 | 546 | Mechanism of action |
| Epoxide hydrolase 1 inhibitor | 1.0 | 104 | Mechanism of action |
| Epoxide hydrolase 2 inhibitor | 1.0 | 386 | Mechanism of action |
| Epoxide hydrolase inhibitor | 0.98 | 2228 | Mechanism of action |
| ErbB-1 antagonist | 0.92 | 22 | Mechanism of action |
| ErbB-2 antagonist | 0.98 | 3861 | Mechanism of action |
| ErbB-3 antagonist | 0.98 | 62 | Mechanism of action |
| ErbB-4 antagonist | 0.98 | 804 | Mechanism of action |
| Erythropoietin receptor agonist | 1.0 | 28 | Mechanism of action |
| Estradiol 17 beta-dehydrogenase 1 inhibitor | 1.0 | 661 | Mechanism of action |
| Estrogen agonist | 0.99 | 1676 | Mechanism of action |
| Estrogen antagonist | 0.96 | 3320 | Mechanism of action |
| Estrogen receptor alpha antagonist | 0.97 | 1762 | Mechanism of action |
| Estrogen receptor beta antagonist | 0.97 | 2126 | Mechanism of action |
| Estrogen-related receptor alpha antagonist | 1.0 | 153 | Mechanism of action |
| Estrogen-related receptor beta antagonist | 1.0 | 37 | Mechanism of action |
| Estrogen-related receptor gamma agonist | 1.0 | 67 | Mechanism of action |
| Estrogen-related receptor gamma antagonist | 0.99 | 55 | Mechanism of action |
| Estrone sulfatase inhibitor | 1.0 | 590 | Mechanism of action |
| Expectorant | 0.97 | 260 | Mechanism of action |
| Factor III inhibitor | 0.98 | 74 | Mechanism of action |
| Factor IX inhibitor | 1.0 | 393 | Mechanism of action |
| Factor IXa inhibitor | 0.98 | 154 | Mechanism of action |
| Factor V inhibitor | 0.96 | 25 | Mechanism of action |
| Factor VII inhibitor | 0.99 | 585 | Mechanism of action |
| Factor VIIa inhibitor | 0.99 | 755 | Mechanism of action |
| Factor X inhibitor | 0.99 | 5486 | Mechanism of action |
| Factor XI inhibitor | 0.99 | 1536 | Mechanism of action |
| Factor XII inhibitor | 0.97 | 281 | Mechanism of action |
| Factor XIII inhibitor | 0.99 | 89 | Mechanism of action |
| Factor XIIIa inhibitor | 0.99 | 568 | Mechanism of action |
| Factor XIa inhibitor | 0.99 | 647 | Mechanism of action |
| Factor Xa inhibitor | 0.99 | 4167 | Mechanism of action |
| Falcipain 2 inhibitor | 0.97 | 351 | Mechanism of action |
| Falcipain 3 inhibitor | 0.98 | 62 | Mechanism of action |
| Falcipain inhibitor | 0.97 | 355 | Mechanism of action |
| Farnesoid X receptor agonist | 0.99 | 1073 | Mechanism of action |
| Farnesoid X receptor antagonist | 0.95 | 167 | Mechanism of action |
| Farnesyltransferase inhibitor | 0.99 | 3984 | Mechanism of action |
| Fatty acid synthase inhibitor | 0.98 | 521 | Mechanism of action |
| Ferrochelatase inhibitor | 0.99 | 10 | Mechanism of action |
| Fibroblast growth factor 1 antagonist | 0.97 | 3915 | Mechanism of action |
| Fibroblast growth factor 2 antagonist | 0.98 | 1872 | Mechanism of action |
| Fibroblast growth factor 3 antagonist | 0.98 | 2365 | Mechanism of action |
| Fibroblast growth factor 4 antagonist | 0.99 | 1317 | Mechanism of action |
| Focal adhesion kinase 1 inhibitor | 0.98 | 1425 | Mechanism of action |
| Focal adhesion kinase 2 inhibitor | 0.93 | 494 | Mechanism of action |
| Folate antagonist | 0.96 | 46 | Mechanism of action |
| Follicle-stimulating hormone agonist | 1.0 | 752 | Mechanism of action |
| Follicle-stimulating hormone antagonist | 0.99 | 387 | Mechanism of action |
| Free fatty acid receptor 1 agonist | 1.0 | 1973 | Mechanism of action |
| Free fatty acid receptor 1 antagonist | 1.0 | 150 | Mechanism of action |
| Free radical scavenger | 0.93 | 2641 | Mechanism of action |
| Fructose-1,6-bisphosphatase 1 inhibitor | 1.0 | 385 | Mechanism of action |
| Fructose-1,6-bisphosphatase inhibitor | 0.99 | 530 | Mechanism of action |
| Fumarate hydratase inhibitor | 1.0 | 26 | Mechanism of action |
| G protein-coupled receptor agonist | 0.99 | 2289 | Mechanism of action |
| G-protein-coupled receptor 120 agonist | 1.0 | 358 | Mechanism of action |
| GABA A receptor agonist | 0.97 | 870 | Mechanism of action |
| GABA A receptor antagonist | 0.99 | 3593 | Mechanism of action |
| GABA B receptor agonist | 0.98 | 111 | Mechanism of action |
| GABA B receptor antagonist | 0.99 | 446 | Mechanism of action |
| GABA C receptor agonist | 0.99 | 6 | Mechanism of action |
| GABA C receptor antagonist | 0.98 | 53 | Mechanism of action |
| GABA C receptor rho-1 antagonist | 0.98 | 30 | Mechanism of action |
| GABA C receptor rho-2 antagonist | 0.97 | 16 | Mechanism of action |
| GABA C receptor rho-3 antagonist | 0.92 | 8 | Mechanism of action |
| GABA aminotransferase inhibitor | 0.98 | 73 | Mechanism of action |
| GABA receptor agonist | 0.97 | 1112 | Mechanism of action |
| GABA receptor antagonist | 0.99 | 3842 | Mechanism of action |
| GABA uptake inhibitor | 1.0 | 74 | Mechanism of action |
| GHS receptor agonist | 0.99 | 87 | Mechanism of action |
| GHS receptor antagonist | 0.99 | 179 | Mechanism of action |
| GP IIb/IIIa receptor antagonist | 0.99 | 2592 | Mechanism of action |
| Gastric antisecretory | 0.97 | 2271 | Mechanism of action |
| Gastrin inhibitor | 0.91 | 158 | Mechanism of action |
| Geranylgeranyltransferase I inhibitor | 0.99 | 861 | Mechanism of action |
| Geranylgeranyltransferase inhibitor | 0.99 | 937 | Mechanism of action |
| Geranyltranstransferase inhibitor | 0.99 | 371 | Mechanism of action |
| Glucagon agonist | 1.0 | 161 | Mechanism of action |
| Glucagon receptor antagonist | 0.99 | 1461 | Mechanism of action |
| Glucagon-like peptide 1 agonist | 0.99 | 593 | Mechanism of action |
| Glucagon-like peptide 1 receptor antagonist | 0.99 | 110 | Mechanism of action |
| Glucocorticoid agonist | 1.0 | 1170 | Mechanism of action |
| Glucocorticoid antagonist | 0.99 | 2201 | Mechanism of action |
| Glucokinase regulatory protein inhibitor | 1.0 | 103 | Mechanism of action |
| Glucose-6-phosphate dehydrogenase inhibitor | 0.99 | 48 | Mechanism of action |
| Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.93 | 319 | Mechanism of action |
| Glucose-6-phosphate isomerase inhibitor | 0.96 | 24 | Mechanism of action |
| Glucose-6-phosphate translocase inhibitor | 0.99 | 83 | Mechanism of action |
| Glucose-dependent insulinotropic receptor agonist | 1.0 | 1912 | Mechanism of action |
| Glucose-dependent insulinotropic receptor antagonist | 1.0 | 91 | Mechanism of action |
| Glucosylceramidase inhibitor | 0.98 | 524 | Mechanism of action |
| Glutamate (mGluR group I) agonist | 0.99 | 985 | Mechanism of action |
| Glutamate (mGluR group I) antagonist | 0.98 | 4888 | Mechanism of action |
| Glutamate (mGluR group II) agonist | 0.99 | 900 | Mechanism of action |
| Glutamate (mGluR group II) antagonist | 0.99 | 1355 | Mechanism of action |
| Glutamate (mGluR group III) agonist | 0.99 | 331 | Mechanism of action |
| Glutamate (mGluR group III) antagonist | 0.99 | 259 | Mechanism of action |
| Glutamate (mGluR) agonist | 0.99 | 2183 | Mechanism of action |
| Glutamate (mGluR) antagonist | 0.98 | 6459 | Mechanism of action |
| Glutamate (mGluR1) agonist | 0.99 | 145 | Mechanism of action |
| Glutamate (mGluR1) antagonist | 0.99 | 2190 | Mechanism of action |
| Glutamate (mGluR1a) agonist | 1.0 | 54 | Mechanism of action |
| Glutamate (mGluR1a) antagonist | 0.99 | 297 | Mechanism of action |
| Glutamate (mGluR2) agonist | 0.99 | 885 | Mechanism of action |
| Glutamate (mGluR2) antagonist | 1.0 | 1212 | Mechanism of action |
| Glutamate (mGluR3) agonist | 0.99 | 114 | Mechanism of action |
| Glutamate (mGluR3) antagonist | 0.99 | 312 | Mechanism of action |
| Glutamate (mGluR4) agonist | 0.99 | 250 | Mechanism of action |
| Glutamate (mGluR4) antagonist | 0.99 | 159 | Mechanism of action |
| Glutamate (mGluR5) agonist | 0.99 | 854 | Mechanism of action |
| Glutamate (mGluR5) antagonist | 0.99 | 3014 | Mechanism of action |
| Glutamate (mGluR6) agonist | 1.0 | 52 | Mechanism of action |
| Glutamate (mGluR6) antagonist | 0.97 | 40 | Mechanism of action |
| Glutamate (mGluR7) antagonist | 0.99 | 56 | Mechanism of action |
| Glutamate (mGluR8) agonist | 0.98 | 62 | Mechanism of action |
| Glutamate (mGluR8) antagonist | 0.98 | 47 | Mechanism of action |
| Glutamate decarboxylase inhibitor | 0.99 | 52 | Mechanism of action |
| Glutamate dehydrogenase inhibitor | 0.98 | 40 | Mechanism of action |
| Glutamate receptor agonist | 0.98 | 2635 | Mechanism of action |
| Glutamate receptor antagonist | 0.97 | 13903 | Mechanism of action |
| Glutamate release inhibitor | 0.95 | 71 | Mechanism of action |
| Glutaminyl-peptide cyclotransferase inhibitor | 1.0 | 528 | Mechanism of action |
| Glutathione S-transferase inhibitor | 0.97 | 273 | Mechanism of action |
| Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.92 | 126 | Mechanism of action |
| Glycine receptor agonist | 0.98 | 48 | Mechanism of action |
| Glycine receptor antagonist | 0.98 | 109 | Mechanism of action |
| Glycine transporter 1 inhibitor | 1.0 | 1999 | Mechanism of action |
| Glycine transporter 2 inhibitor | 0.99 | 218 | Mechanism of action |
| Glycine transporter inhibitor | 0.99 | 2174 | Mechanism of action |
| Glycogen synthase kinase-3 alpha inhibitor | 0.96 | 1340 | Mechanism of action |
| Glycogen synthase kinase-3 beta inhibitor | 0.97 | 7741 | Mechanism of action |
| Glycogen synthase kinase-3 inhibitor | 0.97 | 8951 | Mechanism of action |
| Gonadotropin-releasing hormone receptor agonist | 0.97 | 216 | Mechanism of action |
| Gonadotropin-releasing hormone receptor antagonist | 0.99 | 2628 | Mechanism of action |
| Granulocyte colony stimulating factor receptor agonist | 1.0 | 34 | Mechanism of action |
| Granulocyte macrophage colony stimulating factor agonist | 0.98 | 12 | Mechanism of action |
| Granulocyte macrophage colony stimulating factor antagonist | 0.97 | 1408 | Mechanism of action |
| Growth factor agonist | 0.92 | 310 | Mechanism of action |
| Growth factor antagonist | 0.95 | 23076 | Mechanism of action |
| Growth factor receptor-bound protein 2 antagonist | 0.99 | 217 | Mechanism of action |
| Growth hormone agonist | 0.98 | 11 | Mechanism of action |
| Growth hormone release inhibitor | 1.0 | 75 | Mechanism of action |
| Growth hormone release promoting | 1.0 | 399 | Mechanism of action |
| Growth hormone releasing factor agonist | 1.0 | 457 | Mechanism of action |
| Growth hormone releasing factor antagonist | 1.0 | 59 | Mechanism of action |
| Growth hormone secretagogue receptor agonist | 1.0 | 990 | Mechanism of action |
| Growth hormone secretagogue receptor antagonist | 0.99 | 710 | Mechanism of action |
| Guanylate cyclase 1 stimulant | 1.0 | 430 | Mechanism of action |
| Guanylate cyclase inhibitor | 0.99 | 303 | Mechanism of action |
| Guanylate cyclase stimulant | 0.99 | 790 | Mechanism of action |
| H+/K+-transporting ATPase inhibitor | 0.99 | 1570 | Mechanism of action |
| HCV NS3/NS4A protease inhibitor | 0.99 | 2912 | Mechanism of action |
| HCV NS5A inhibitor | 1.0 | 1015 | Mechanism of action |
| HCV NS5B polymerase inhibitor | 0.99 | 1334 | Mechanism of action |
| HCV polyprotein inhibitor | 0.99 | 145 | Mechanism of action |
| HIV-1 integrase (3'-Processing) inhibitor | 0.98 | 510 | Mechanism of action |
| HIV-1 integrase (Overall Integration) inhibitor | 0.97 | 69 | Mechanism of action |
| HIV-1 integrase (Strand Transfer) inhibitor | 0.99 | 532 | Mechanism of action |
| HIV-1 integrase inhibitor | 0.98 | 4260 | Mechanism of action |
| HIV-1 protease inhibitor | 0.99 | 5842 | Mechanism of action |
| HIV-1 reverse transcriptase inhibitor | 0.98 | 4458 | Mechanism of action |
| HMG CoA reductase inhibitor | 1.0 | 2394 | Mechanism of action |
| Heat shock protein 70 antagonist | 0.91 | 76 | Mechanism of action |
| Heat shock protein 90 alpha antagonist | 0.95 | 2090 | Mechanism of action |
| Heat shock protein 90 antagonist | 0.95 | 3462 | Mechanism of action |
| Heat shock protein 90 beta antagonist | 0.98 | 564 | Mechanism of action |
| Hedgehog signaling activator | 0.97 | 30 | Mechanism of action |
| Hedgehog signaling inhibitor | 0.96 | 607 | Mechanism of action |
| Hematopoietic | 0.96 | 229 | Mechanism of action |
| Heme oxygenase inhibitor | 0.98 | 154 | Mechanism of action |
| Heme oxygenase stimulant | 0.99 | 10 | Mechanism of action |
| Hemostatic | 0.94 | 824 | Mechanism of action |
| Heparanase inhibitor | 0.98 | 328 | Mechanism of action |
| Hepatocyte growth factor antagonist | 0.97 | 4855 | Mechanism of action |
| Hepatoprotectant | 0.93 | 1031 | Mechanism of action |
| Hexokinase inhibitor | 0.94 | 380 | Mechanism of action |
| Hexokinase stimulant | 1.0 | 1570 | Mechanism of action |
| Histamine H1 receptor agonist | 0.99 | 76 | Mechanism of action |
| Histamine H1 receptor antagonist | 0.98 | 2938 | Mechanism of action |
| Histamine H2 receptor agonist | 0.99 | 209 | Mechanism of action |
| Histamine H2 receptor antagonist | 0.97 | 796 | Mechanism of action |
| Histamine H3 receptor agonist | 1.0 | 550 | Mechanism of action |
| Histamine H3 receptor antagonist | 0.99 | 5057 | Mechanism of action |
| Histamine H4 receptor agonist | 1.0 | 381 | Mechanism of action |
| Histamine H4 receptor antagonist | 0.99 | 638 | Mechanism of action |
| Histamine N-methyltransferase inhibitor | 0.98 | 80 | Mechanism of action |
| Histamine agonist | 0.99 | 1060 | Mechanism of action |
| Histamine antagonist | 0.97 | 8774 | Mechanism of action |
| Histamine release inhibitor | 0.88 | 121 | Mechanism of action |
| Histidine decarboxylase inhibitor | 0.99 | 45 | Mechanism of action |
| Histone acetyltransferase inhibitor | 0.92 | 1099 | Mechanism of action |
| Histone deacetylase 1 inhibitor | 0.99 | 4723 | Mechanism of action |
| Histone deacetylase 10 inhibitor | 1.0 | 448 | Mechanism of action |
| Histone deacetylase 11 inhibitor | 0.99 | 551 | Mechanism of action |
| Histone deacetylase 2 inhibitor | 0.99 | 2033 | Mechanism of action |
| Histone deacetylase 3 inhibitor | 0.99 | 1612 | Mechanism of action |
| Histone deacetylase 4 inhibitor | 0.99 | 959 | Mechanism of action |
| Histone deacetylase 5 inhibitor | 0.99 | 1870 | Mechanism of action |
| Histone deacetylase 6 inhibitor | 0.99 | 3391 | Mechanism of action |
| Histone deacetylase 7 inhibitor | 0.99 | 527 | Mechanism of action |
| Histone deacetylase 8 inhibitor | 0.99 | 1594 | Mechanism of action |
| Histone deacetylase 9 inhibitor | 0.99 | 499 | Mechanism of action |
| Histone deacetylase SIRT1 inhibitor | 0.95 | 337 | Mechanism of action |
| Histone deacetylase SIRT1 stimulant | 0.98 | 311 | Mechanism of action |
| Histone deacetylase SIRT2 inhibitor | 0.98 | 586 | Mechanism of action |
| Histone deacetylase class I inhibitor | 0.99 | 5913 | Mechanism of action |
| Histone deacetylase class II inhibitor | 0.99 | 4794 | Mechanism of action |
| Histone deacetylase class III inhibitor | 0.96 | 803 | Mechanism of action |
| Histone deacetylase class IIa inhibitor | 0.99 | 2410 | Mechanism of action |
| Histone deacetylase class IIb inhibitor | 0.99 | 3412 | Mechanism of action |
| Histone deacetylase class IV inhibitor | 0.99 | 551 | Mechanism of action |
| Histone deacetylase inhibitor | 0.98 | 10433 | Mechanism of action |
| Histone deacetylase stimulant | 0.98 | 311 | Mechanism of action |
| Histone-lysine N-methyltransferase EZH2 inhibitor | 0.99 | 749 | Mechanism of action |
| Human T-cell leukemia virus type I protease inhibitor | 1.0 | 48 | Mechanism of action |
| Human herpes virus 5 capsid protein P40 inhibitor | 1.0 | 158 | Mechanism of action |
| Human herpesvirus 2 protease inhibitor | 1.0 | 42 | Mechanism of action |
| Human rhinovirus A protease inhibitor | 0.98 | 289 | Mechanism of action |
| Hypoglycemic | 0.91 | 2404 | Mechanism of action |
| Hypolipemic | 0.93 | 11143 | Mechanism of action |
| Hypoxanthine phosphoribosyltransferase inhibitor | 1.0 | 164 | Mechanism of action |
| I kappa B kinase 1 inhibitor | 0.98 | 587 | Mechanism of action |
| I kappa B kinase 2 inhibitor | 0.98 | 2265 | Mechanism of action |
| I kappa B kinase epsilon inhibitor | 0.95 | 211 | Mechanism of action |
| I kappa B kinase inhibitor | 0.98 | 2910 | Mechanism of action |
| ICAM 1 antagonist | 0.99 | 427 | Mechanism of action |
| Ileal bile acid transport inhibitor | 1.0 | 329 | Mechanism of action |
| Imidazoline I1 receptor antagonist | 1.0 | 182 | Mechanism of action |
| Imidazoline I2 receptor antagonist | 1.0 | 140 | Mechanism of action |
| Immunoglobulin Fc receptor antagonist | 0.97 | 86 | Mechanism of action |
| Immunomodulator | 0.89 | 6199 | Mechanism of action |
| Immunostimulant | 0.92 | 1564 | Mechanism of action |
| Immunosuppressant | 0.89 | 5623 | Mechanism of action |
| Immunosuppressant Cyclosporine-like | 1.0 | 19 | Mechanism of action |
| Inducible nitric-oxide synthase inhibitor | 0.98 | 1660 | Mechanism of action |
| Inosine monophosphate dehydrogenase 1 inhibitor | 1.0 | 156 | Mechanism of action |
| Inosine monophosphate dehydrogenase 2 inhibitor | 1.0 | 671 | Mechanism of action |
| Inosine monophosphate dehydrogenase inhibitor | 0.99 | 1036 | Mechanism of action |
| Insulin growth factor antagonist | 0.98 | 3855 | Mechanism of action |
| Insulin like growth factor 1 antagonist | 0.98 | 3811 | Mechanism of action |
| Insulin like growth factor 3 antagonist | 1.0 | 44 | Mechanism of action |
| Insulin receptor antagonist | 0.97 | 1479 | Mechanism of action |
| Insulin secretagoues | 0.94 | 524 | Mechanism of action |
| Insulin sensitizer | 0.94 | 356 | Mechanism of action |
| Insulysin inhibitor | 0.9 | 132 | Mechanism of action |
| Integrin alpha1beta1 antagonist | 0.99 | 43 | Mechanism of action |
| Integrin alpha2 antagonist | 0.99 | 79 | Mechanism of action |
| Integrin alpha2beta1 antagonist | 1.0 | 69 | Mechanism of action |
| Integrin alpha4 antagonist | 1.0 | 2552 | Mechanism of action |
| Integrin alpha4beta1 antagonist | 1.0 | 1893 | Mechanism of action |
| Integrin alpha4beta7 antagonist | 1.0 | 912 | Mechanism of action |
| Integrin alpha5beta1 antagonist | 0.99 | 318 | Mechanism of action |
| Integrin alpha5beta6 antagonist | 1.0 | 42 | Mechanism of action |
| Integrin alphaLbeta2 antagonist | 1.0 | 401 | Mechanism of action |
| Integrin alphaVbeta1 antagonist | 1.0 | 151 | Mechanism of action |
| Integrin alphaVbeta3 antagonist | 1.0 | 781 | Mechanism of action |
| Integrin alphaVbeta5 antagonist | 1.0 | 456 | Mechanism of action |
| Integrin alphaVbeta6 antagonist | 1.0 | 358 | Mechanism of action |
| Integrin antagonist | 0.99 | 5386 | Mechanism of action |
| Integrin beta2 antagonist | 1.0 | 373 | Mechanism of action |
| Integrin beta3 antagonist | 1.0 | 988 | Mechanism of action |
| Integrin beta5 antagonist | 1.0 | 173 | Mechanism of action |
| Integrin beta6 antagonist | 1.0 | 102 | Mechanism of action |
| Integrin beta7 antagonist | 1.0 | 356 | Mechanism of action |
| Interferon agonist | 0.98 | 224 | Mechanism of action |
| Interferon gamma antagonist | 0.94 | 130 | Mechanism of action |
| Interferon inducer | 0.98 | 200 | Mechanism of action |
| Interleukin 1 antagonist | 0.95 | 969 | Mechanism of action |
| Interleukin 1 beta converting enzyme inhibitor | 0.97 | 1644 | Mechanism of action |
| Interleukin 12 antagonist | 0.96 | 134 | Mechanism of action |
| Interleukin 1b antagonist | 0.96 | 532 | Mechanism of action |
| Interleukin 2 agonist | 0.91 | 17 | Mechanism of action |
| Interleukin 2 antagonist | 0.95 | 256 | Mechanism of action |
| Interleukin 4 antagonist | 0.95 | 148 | Mechanism of action |
| Interleukin 5 antagonist | 0.97 | 161 | Mechanism of action |
| Interleukin 6 antagonist | 0.94 | 270 | Mechanism of action |
| Interleukin 8 antagonist | 0.96 | 268 | Mechanism of action |
| Interleukin agonist | 0.93 | 63 | Mechanism of action |
| Interleukin antagonist | 0.93 | 2444 | Mechanism of action |
| Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.95 | 356 | Mechanism of action |
| Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.98 | 1959 | Mechanism of action |
| Isoleucine-tRNA ligase inhibitor | 1.0 | 116 | Mechanism of action |
| Janus tyrosine kinase 1 inhibitor | 0.99 | 5215 | Mechanism of action |
| Janus tyrosine kinase 2 inhibitor | 0.98 | 9456 | Mechanism of action |
| Janus tyrosine kinase 3 inhibitor | 0.98 | 6985 | Mechanism of action |
| Kainate receptor 1 antagonist | 1.0 | 421 | Mechanism of action |
| Kainate receptor 2 antagonist | 1.0 | 287 | Mechanism of action |
| Kainate receptor 3 antagonist | 1.0 | 160 | Mechanism of action |
| Kainate receptor 4 antagonist | 1.0 | 135 | Mechanism of action |
| Kainate receptor 5 antagonist | 1.0 | 164 | Mechanism of action |
| Kainate receptor agonist | 0.99 | 38 | Mechanism of action |
| Kainate receptor antagonist | 0.99 | 644 | Mechanism of action |
| Kallikrein 1 inhibitor | 0.97 | 236 | Mechanism of action |
| Kallikrein 7 inhibitor | 0.98 | 157 | Mechanism of action |
| Kallikrein inhibitor | 0.99 | 1797 | Mechanism of action |
| Keratolytic | 0.98 | 69 | Mechanism of action |
| KiSS-1 receptor agonist | 1.0 | 276 | Mechanism of action |
| KiSS-1 receptor antagonist | 1.0 | 51 | Mechanism of action |
| Kinesin antagonist | 0.99 | 1328 | Mechanism of action |
| Kinesin-like protein 1 inhibitor | 0.99 | 1328 | Mechanism of action |
| Kynurenine 3 monooxygenase inhibitor | 1.0 | 347 | Mechanism of action |
| LFA antagonist | 0.99 | 450 | Mechanism of action |
| LIM domain kinase 1 inhibitor | 0.95 | 548 | Mechanism of action |
| LIM domain kinase 2 inhibitor | 0.99 | 215 | Mechanism of action |
| Lanosterol 14 alpha demethylase inhibitor | 0.97 | 135 | Mechanism of action |
| Lck kinase inhibitor | 0.96 | 3725 | Mechanism of action |
| Leucine-rich repeat kinase 2 inhibitor | 0.98 | 1997 | Mechanism of action |
| Leukocyte elastase inhibitor | 0.99 | 1394 | Mechanism of action |
| Leukotriene A4 hydrolase inhibitor | 1.0 | 675 | Mechanism of action |
| Leukotriene B4 antagonist | 0.99 | 1127 | Mechanism of action |
| Leukotriene B4 receptor 1 antagonist | 1.0 | 672 | Mechanism of action |
| Leukotriene B4 receptor 2 antagonist | 1.0 | 276 | Mechanism of action |
| Leukotriene C antagonist | 0.98 | 301 | Mechanism of action |
| Leukotriene C4 antagonist | 0.99 | 290 | Mechanism of action |
| Leukotriene D4 antagonist | 1.0 | 1557 | Mechanism of action |
| Leukotriene antagonist | 0.98 | 3399 | Mechanism of action |
| Leukotriene synthesis inhibitor | 0.98 | 957 | Mechanism of action |
| Lipase inhibitor | 0.98 | 711 | Mechanism of action |
| Lipid peroxidase inhibitor | 0.96 | 1157 | Mechanism of action |
| Lipocortins synthesis agonist | 0.97 | 81 | Mechanism of action |
| Lipocortins synthesis antagonist | 0.97 | 11 | Mechanism of action |
| Lipoxygenase inhibitor | 0.91 | 9550 | Mechanism of action |
| Liver X receptor agonist | 0.99 | 1164 | Mechanism of action |
| Liver X receptor alpha agonist | 0.99 | 687 | Mechanism of action |
| Liver X receptor antagonist | 0.99 | 404 | Mechanism of action |
| Liver X receptor beta agonist | 0.99 | 830 | Mechanism of action |
| Lysine carboxypeptidase inhibitor | 1.0 | 44 | Mechanism of action |
| Lysophosphatidic acid 1 receptor antagonist | 0.99 | 425 | Mechanism of action |
| Lysophosphatidic acid 2 receptor antagonist | 1.0 | 83 | Mechanism of action |
| Lysophosphatidic acid 3 receptor antagonist | 0.99 | 82 | Mechanism of action |
| Lysophosphatidic acid receptor 3 agonist | 1.0 | 27 | Mechanism of action |
| M17 leucyl aminopeptidase inhibitor | 0.97 | 279 | Mechanism of action |
| M18 aspartyl aminopeptidase inhibitor | 0.97 | 123 | Mechanism of action |
| MAO A inhibitor | 0.97 | 2623 | Mechanism of action |
| MAO B inhibitor | 0.98 | 3993 | Mechanism of action |
| MAO inhibitor | 0.96 | 5366 | Mechanism of action |
| MAP kinase 1 inhibitor | 0.85 | 5940 | Mechanism of action |
| MAP kinase 10 inhibitor | 0.98 | 1557 | Mechanism of action |
| MAP kinase 11 inhibitor | 0.98 | 1056 | Mechanism of action |
| MAP kinase 12 inhibitor | 0.96 | 602 | Mechanism of action |
| MAP kinase 13 inhibitor | 0.96 | 581 | Mechanism of action |
| MAP kinase 14 inhibitor | 0.98 | 7842 | Mechanism of action |
| MAP kinase 3 inhibitor | 0.94 | 363 | Mechanism of action |
| MAP kinase 7 inhibitor | 0.97 | 97 | Mechanism of action |
| MAP kinase 8 inhibitor | 0.97 | 1531 | Mechanism of action |
| MAP kinase 9 inhibitor | 0.97 | 1167 | Mechanism of action |
| MAP kinase kinase 1 inhibitor | 0.97 | 1677 | Mechanism of action |
| MAP kinase kinase 2 inhibitor | 0.94 | 268 | Mechanism of action |
| MAP kinase kinase 3 inhibitor | 0.88 | 13 | Mechanism of action |
| MAP kinase kinase 4 inhibitor | 0.94 | 62 | Mechanism of action |
| MAP kinase kinase 5 inhibitor | 0.92 | 24 | Mechanism of action |
| MAP kinase kinase 6 inhibitor | 0.87 | 36 | Mechanism of action |
| MAP kinase kinase 7 inhibitor | 0.97 | 171 | Mechanism of action |
| MAP kinase kinase inhibitor | 0.96 | 2890 | Mechanism of action |
| MAP kinase kinase kinase inhibitor | 0.97 | 2175 | Mechanism of action |
| MAP-kinase-activated kinase 2 inhibitor | 0.98 | 2280 | Mechanism of action |
| MAP-kinase-activated kinase 5 inhibitor | 0.91 | 178 | Mechanism of action |
| MAP-kinase-activated kinase inhibitor | 0.97 | 2410 | Mechanism of action |
| MAP3K5 inhibitor | 0.99 | 541 | Mechanism of action |
| MAP3K7 inhibitor | 0.98 | 294 | Mechanism of action |
| MAP3K8 inhibitor | 0.99 | 980 | Mechanism of action |
| MAP3K9 inhibitor | 0.95 | 118 | Mechanism of action |
| MDM2 inhibitor | 0.97 | 506 | Mechanism of action |
| Macrophage colony-stimulating factor 1 receptor antagonist | 0.98 | 2645 | Mechanism of action |
| Macrophage elastase inhibitor | 0.99 | 744 | Mechanism of action |
| Macrophage migration inhibitory factor inhibitor | 0.98 | 293 | Mechanism of action |
| Maillard reaction inhibitor | 0.99 | 173 | Mechanism of action |
| Mannitol 2-dehydrogenase inhibitor | 1.0 | 5 | Mechanism of action |
| Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.99 | 18 | Mechanism of action |
| Mannose-6-phosphate isomerase inhibitor | 0.96 | 132 | Mechanism of action |
| Mannosidase inhibitor | 0.99 | 125 | Mechanism of action |
| Matrix metalloproteinase (membrane-type) inhibitor | 0.99 | 2118 | Mechanism of action |
| Matrix metalloproteinase 1 inhibitor | 0.99 | 2560 | Mechanism of action |
| Matrix metalloproteinase inhibitor | 0.98 | 4483 | Mechanism of action |
| Mcl-1 antagonist | 0.95 | 1945 | Mechanism of action |
| Mediator release inhibitor | 0.97 | 662 | Mechanism of action |
| Melanin inhibitor | 0.94 | 122 | Mechanism of action |
| Melanin-concentrating hormone receptor 1 antagonist | 0.99 | 3485 | Mechanism of action |
| Melanocortin 1 agonist | 1.0 | 754 | Mechanism of action |
| Melanocortin 1 antagonist | 0.99 | 343 | Mechanism of action |
| Melanocortin 3 agonist | 1.0 | 716 | Mechanism of action |
| Melanocortin 3 antagonist | 1.0 | 545 | Mechanism of action |
| Melanocortin 4 agonist | 1.0 | 2140 | Mechanism of action |
| Melanocortin 4 antagonist | 0.99 | 1754 | Mechanism of action |
| Melanocortin 5 agonist | 1.0 | 579 | Mechanism of action |
| Melanocortin 5 antagonist | 0.99 | 841 | Mechanism of action |
| Melanocortin agonist | 1.0 | 2503 | Mechanism of action |
| Melanocortin antagonist | 0.99 | 2449 | Mechanism of action |
| Melatonin 1 agonist | 0.99 | 349 | Mechanism of action |
| Melatonin 1 antagonist | 1.0 | 1156 | Mechanism of action |
| Melatonin 2 agonist | 1.0 | 188 | Mechanism of action |
| Melatonin 2 antagonist | 1.0 | 238 | Mechanism of action |
| Melatonin 3 antagonist | 1.0 | 100 | Mechanism of action |
| Melatonin 5 antagonist | 1.0 | 68 | Mechanism of action |
| Melatonin agonist | 0.99 | 593 | Mechanism of action |
| Melatonin antagonist | 1.0 | 1290 | Mechanism of action |
| Membrane dipeptidase inhibitor | 0.99 | 188 | Mechanism of action |
| Metalloproteinase-2 inhibitor | 0.98 | 3497 | Mechanism of action |
| Metalloproteinase-3 inhibitor | 0.99 | 1056 | Mechanism of action |
| Metalloproteinase-9 inhibitor | 0.98 | 2907 | Mechanism of action |
| Methionyl aminopeptidase 1 inhibitor | 1.0 | 296 | Mechanism of action |
| Methionyl aminopeptidase 2 inhibitor | 1.0 | 871 | Mechanism of action |
| Methylmalonyl-CoA mutase inhibitor | 0.99 | 11 | Mechanism of action |
| Microsomal triglyceride transfer protein inhibitor | 1.0 | 520 | Mechanism of action |
| Microtubule formation inhibitor | 0.96 | 613 | Mechanism of action |
| Microtubule stabilization | 0.99 | 768 | Mechanism of action |
| Mineralocorticoid receptor antagonist | 0.99 | 1125 | Mechanism of action |
| Monophenol monooxygenase inhibitor | 0.97 | 894 | Mechanism of action |
| Motilin receptor agonist | 1.0 | 352 | Mechanism of action |
| Motilin receptor antagonist | 0.99 | 136 | Mechanism of action |
| Mucolytic | 0.97 | 196 | Mechanism of action |
| Multidrug resistance-associated protein 1 inhibitor | 0.97 | 391 | Mechanism of action |
| Myc inhibitor | 0.99 | 507 | Mechanism of action |
| Myeloperoxidase inhibitor | 0.98 | 406 | Mechanism of action |
| Myristoyl transferase inhibitor | 0.99 | 700 | Mechanism of action |
| N-Acetylated alpha-linked acidic dipeptidase inhibitor | 1.0 | 464 | Mechanism of action |
| NAD(P)H dehydrogenase (quinone) inhibitor | 0.98 | 262 | Mechanism of action |
| NADH dehydrogenase inhibitor | 0.97 | 19 | Mechanism of action |
| NADPH oxidase inhibitor | 0.95 | 410 | Mechanism of action |
| NMDA 2 receptor antagonist | 0.99 | 1786 | Mechanism of action |
| NMDA 2A receptor antagonist | 0.99 | 689 | Mechanism of action |
| NMDA 2B receptor antagonist | 0.99 | 929 | Mechanism of action |
| NMDA receptor agonist | 0.98 | 186 | Mechanism of action |
| NMDA receptor antagonist | 0.98 | 6006 | Mechanism of action |
| NMDA receptor glycine site agonist | 0.99 | 129 | Mechanism of action |
| NMDA receptor glycine site antagonist | 1.0 | 731 | Mechanism of action |
| NMDA receptor phencyclidine site antagonist | 1.0 | 185 | Mechanism of action |
| NMDA receptor subunit 3A antagonist | 0.99 | 1034 | Mechanism of action |
| NMDA receptor subunit 3B antagonist | 0.99 | 632 | Mechanism of action |
| NOS3 expression enhancer | 0.94 | 124 | Mechanism of action |
| Na+ K+ transporting ATPase inhibitor | 0.98 | 345 | Mechanism of action |
| Nav1.1 sodium channel blocker | 0.96 | 235 | Mechanism of action |
| Nav1.2 sodium channel blocker | 0.95 | 488 | Mechanism of action |
| Nav1.3 sodium channel blocker | 0.96 | 389 | Mechanism of action |
| Nav1.4 sodium channel blocker | 0.96 | 173 | Mechanism of action |
| Nav1.5 sodium channel blocker | 0.96 | 874 | Mechanism of action |
| Nav1.6 sodium channel blocker | 0.96 | 298 | Mechanism of action |
| Nav1.7 sodium channel blocker | 0.98 | 6191 | Mechanism of action |
| Nav1.8 sodium channel blocker | 0.98 | 788 | Mechanism of action |
| Nerve growth factor antagonist | 1.0 | 60 | Mechanism of action |
| Neuraminidase (Influenza A) inhibitor | 0.99 | 272 | Mechanism of action |
| Neuraminidase (Influenza B) inhibitor | 0.99 | 78 | Mechanism of action |
| Neuraminidase (influenza) inhibitor | 0.98 | 961 | Mechanism of action |
| Neuraminidase inhibitor | 0.99 | 1546 | Mechanism of action |
| Neurokinin 1 agonist | 0.99 | 42 | Mechanism of action |
| Neurokinin 1 antagonist | 0.99 | 4539 | Mechanism of action |
| Neurokinin 2 agonist | 0.99 | 44 | Mechanism of action |
| Neurokinin 2 antagonist | 0.99 | 1751 | Mechanism of action |
| Neurokinin 3 agonist | 1.0 | 68 | Mechanism of action |
| Neurokinin 3 antagonist | 0.99 | 1515 | Mechanism of action |
| Neurokinin antagonist | 0.99 | 6147 | Mechanism of action |
| Neuronal nicotinic receptor antagonist | 0.98 | 2343 | Mechanism of action |
| Neuropeptide Y antagonist | 0.97 | 2712 | Mechanism of action |
| Neuropeptide Y1 antagonist | 0.95 | 659 | Mechanism of action |
| Neuropeptide Y2 antagonist | 0.91 | 303 | Mechanism of action |
| Neuropeptide Y5 antagonist | 0.99 | 1446 | Mechanism of action |
| Neuropeptide agonist | 0.98 | 297 | Mechanism of action |
| Neurotensin receptor agonist | 0.93 | 212 | Mechanism of action |
| Neurotensin receptor antagonist | 0.98 | 252 | Mechanism of action |
| Neurotrophic factor | 0.96 | 524 | Mechanism of action |
| Neurotrophic factor enhancer | 0.93 | 77 | Mechanism of action |
| Neutral endopeptidase inhibitor | 1.0 | 1891 | Mechanism of action |
| Neutrophil collagenase inhibitor | 0.99 | 1192 | Mechanism of action |
| Nicotinamide phosphoribosyltransferase inhibitor | 1.0 | 2437 | Mechanism of action |
| Nicotinic acid receptor 1 agonist | 0.99 | 287 | Mechanism of action |
| Nicotinic acid receptor 1 antagonist | 1.0 | 88 | Mechanism of action |
| Nicotinic acid receptor 2 agonist | 0.99 | 605 | Mechanism of action |
| Nicotinic acid receptor 2 antagonist | 1.0 | 155 | Mechanism of action |
| Nicotinic acid receptor agonist | 0.99 | 896 | Mechanism of action |
| Nicotinic alpha3beta2 receptor antagonist | 0.98 | 142 | Mechanism of action |
| Nicotinic alpha3beta4 receptor agonist | 1.0 | 127 | Mechanism of action |
| Nicotinic alpha4 receptor agonist | 1.0 | 301 | Mechanism of action |
| Nicotinic alpha4beta2 receptor agonist | 1.0 | 261 | Mechanism of action |
| Nicotinic alpha4beta2 receptor antagonist | 0.98 | 434 | Mechanism of action |
| Nicotinic alpha7 receptor agonist | 0.99 | 975 | Mechanism of action |
| Nicotinic neuronal receptor agonist | 0.99 | 1367 | Mechanism of action |
| Nicotinic receptor alpha3 subunit antagonist | 0.99 | 317 | Mechanism of action |
| Nicotinic receptor alpha4 subunit antagonist | 0.99 | 994 | Mechanism of action |
| Nicotinic receptor alpha7 subunit antagonist | 0.99 | 841 | Mechanism of action |
| Nicotinic receptor beta4 subunit antagonist | 0.99 | 232 | Mechanism of action |
| Nitric oxide antagonist | 0.93 | 1786 | Mechanism of action |
| Nitric oxide donor | 0.98 | 1179 | Mechanism of action |
| Nitric-oxide synthase inhibitor | 0.97 | 3094 | Mechanism of action |
| Nitric-oxide synthase stimulant | 0.9 | 21 | Mechanism of action |
| Nociceptin (N/OFQ) receptor agonist | 1.0 | 702 | Mechanism of action |
| Nociceptin (N/OFQ) receptor antagonist | 1.0 | 907 | Mechanism of action |
| Non-steroidal antiinflammatory agent | 0.93 | 1296 | Mechanism of action |
| Nootropic | 0.89 | 6850 | Mechanism of action |
| O6-alkylguanine-DNA alkyltransferase inhibitor | 0.99 | 167 | Mechanism of action |
| Oleamide hydrolase inhibitor | 0.99 | 2116 | Mechanism of action |
| Opioid agonist | 0.99 | 5478 | Mechanism of action |
| Opioid antagonist | 0.97 | 7268 | Mechanism of action |
| Opioid delta receptor agonist | 0.99 | 2063 | Mechanism of action |
| Opioid delta receptor antagonist | 0.98 | 3751 | Mechanism of action |
| Opioid kappa receptor agonist | 0.99 | 1983 | Mechanism of action |
| Opioid kappa receptor antagonist | 0.97 | 3884 | Mechanism of action |
| Opioid mu receptor agonist | 0.99 | 2582 | Mechanism of action |
| Opioid mu receptor antagonist | 0.98 | 5265 | Mechanism of action |
| Orexin receptor 1 antagonist | 0.98 | 3457 | Mechanism of action |
| Orexin receptor 2 antagonist | 1.0 | 3309 | Mechanism of action |
| Orexin receptor antagonist | 0.98 | 4646 | Mechanism of action |
| Ornithine carbamoyltransferase inhibitor | 0.99 | 44 | Mechanism of action |
| Ornithine decarboxylase inhibitor | 0.98 | 290 | Mechanism of action |
| Oxytocin agonist | 0.99 | 261 | Mechanism of action |
| Oxytocin antagonist | 0.99 | 1422 | Mechanism of action |
| P-glycoprotein inhibitor | 0.93 | 1630 | Mechanism of action |
| Parathyroid hormone antagonist | 0.99 | 65 | Mechanism of action |
| Peptide deformylase inhibitor | 0.99 | 460 | Mechanism of action |
| Peptidyltransferase inhibitor | 0.91 | 20 | Mechanism of action |
| Peroxidase inhibitor | 0.96 | 24 | Mechanism of action |
| Peroxisome proliferator-activated receptor alpha agonist | 0.99 | 2717 | Mechanism of action |
| Peroxisome proliferator-activated receptor alpha antagonist | 1.0 | 937 | Mechanism of action |
| Peroxisome proliferator-activated receptor delta agonist | 0.99 | 1480 | Mechanism of action |
| Peroxisome proliferator-activated receptor delta antagonist | 0.99 | 409 | Mechanism of action |
| Peroxisome proliferator-activated receptor gamma agonist | 0.98 | 3444 | Mechanism of action |
| Peroxisome proliferator-activated receptor gamma antagonist | 0.98 | 1725 | Mechanism of action |
| Phenylalanine 4-hydroxylase inhibitor | 0.99 | 40 | Mechanism of action |
| Phenylethanolamine N methyltransferase inhibitor | 0.99 | 170 | Mechanism of action |
| Phosphatidylinositol 3-kinase alpha inhibitor | 0.99 | 9529 | Mechanism of action |
| Phosphatidylinositol 3-kinase beta inhibitor | 0.99 | 2480 | Mechanism of action |
| Phosphatidylinositol 3-kinase delta inhibitor | 0.99 | 3732 | Mechanism of action |
| Phosphatidylinositol 3-kinase gamma inhibitor | 0.99 | 5887 | Mechanism of action |
| Phosphatidylinositol kinase inhibitor | 0.98 | 14607 | Mechanism of action |
| Phosphodiesterase 10A inhibitor | 0.99 | 5287 | Mechanism of action |
| Phosphodiesterase 11A inhibitor | 0.97 | 170 | Mechanism of action |
| Phosphodiesterase 1A inhibitor | 0.98 | 312 | Mechanism of action |
| Phosphodiesterase 1B inhibitor | 0.98 | 414 | Mechanism of action |
| Phosphodiesterase 1C inhibitor | 0.98 | 302 | Mechanism of action |
| Phosphodiesterase 2A inhibitor | 0.99 | 1029 | Mechanism of action |
| Phosphodiesterase 3A inhibitor | 0.98 | 546 | Mechanism of action |
| Phosphodiesterase 3B inhibitor | 0.99 | 668 | Mechanism of action |
| Phosphodiesterase 4A inhibitor | 0.99 | 2056 | Mechanism of action |
| Phosphodiesterase 4B inhibitor | 0.98 | 2887 | Mechanism of action |
| Phosphodiesterase 4C inhibitor | 0.99 | 966 | Mechanism of action |
| Phosphodiesterase 4D inhibitor | 0.98 | 1797 | Mechanism of action |
| Phosphodiesterase 5A inhibitor | 0.98 | 2801 | Mechanism of action |
| Phosphodiesterase 6A inhibitor | 1.0 | 186 | Mechanism of action |
| Phosphodiesterase 6B inhibitor | 1.0 | 106 | Mechanism of action |
| Phosphodiesterase 6C inhibitor | 0.98 | 127 | Mechanism of action |
| Phosphodiesterase 6D inhibitor | 0.96 | 232 | Mechanism of action |
| Phosphodiesterase 6G inhibitor | 1.0 | 96 | Mechanism of action |
| Phosphodiesterase 6H inhibitor | 1.0 | 96 | Mechanism of action |
| Phosphodiesterase 7A inhibitor | 0.99 | 611 | Mechanism of action |
| Phosphodiesterase 7B inhibitor | 0.97 | 68 | Mechanism of action |
| Phosphodiesterase 9A inhibitor | 0.99 | 604 | Mechanism of action |
| Phosphodiesterase I inhibitor | 0.97 | 845 | Mechanism of action |
| Phosphodiesterase II inhibitor | 0.99 | 1046 | Mechanism of action |
| Phosphodiesterase III inhibitor | 0.98 | 1712 | Mechanism of action |
| Phosphodiesterase IV inhibitor | 0.98 | 7501 | Mechanism of action |
| Phosphodiesterase IX inhibitor | 0.99 | 731 | Mechanism of action |
| Phosphodiesterase V inhibitor | 0.98 | 2924 | Mechanism of action |
| Phosphodiesterase VI inhibitor | 0.97 | 505 | Mechanism of action |
| Phosphodiesterase VII inhibitor | 0.99 | 890 | Mechanism of action |
| Phosphodiesterase VIII inhibitor | 0.98 | 151 | Mechanism of action |
| Phosphodiesterase X inhibitor | 0.99 | 5287 | Mechanism of action |
| Phosphodiesterase XI inhibitor | 0.97 | 170 | Mechanism of action |
| Phosphodiesterase inhibitor | 0.96 | 19589 | Mechanism of action |
| Phosphofructokinase-1 inhibitor | 0.99 | 34 | Mechanism of action |
| Phosphoglycerate kinase inhibitor | 0.99 | 290 | Mechanism of action |
| Phospholipase A2 inhibitor | 0.95 | 2217 | Mechanism of action |
| Phospholipase C inhibitor | 0.93 | 117 | Mechanism of action |
| Phospholipase D inhibitor | 0.98 | 176 | Mechanism of action |
| Phosphoribosylglycinamide formyltransferase inhibitor | 1.0 | 244 | Mechanism of action |
| Phosphorylase inhibitor | 0.99 | 992 | Mechanism of action |
| Photosensitizer | 0.96 | 86 | Mechanism of action |
| Pim-1 kinase inhibitor | 0.97 | 3467 | Mechanism of action |
| Pim-2 kinase inhibitor | 0.99 | 1967 | Mechanism of action |
| Pim-3 kinase inhibitor | 0.98 | 1575 | Mechanism of action |
| Plasma kallikrein inhibitor | 0.99 | 1269 | Mechanism of action |
| Plasmepsin I inhibitor | 1.0 | 173 | Mechanism of action |
| Plasmepsin II inhibitor | 0.99 | 607 | Mechanism of action |
| Plasmin inhibitor | 0.99 | 1009 | Mechanism of action |
| Plasminogen activator inhibitor | 0.99 | 340 | Mechanism of action |
| Plasminogen activator inhibitor antagonist | 0.99 | 426 | Mechanism of action |
| Platelet activating factor alpha antagonist | 0.97 | 2266 | Mechanism of action |
| Platelet activating factor antagonist | 0.97 | 8398 | Mechanism of action |
| Platelet activating factor beta antagonist | 0.97 | 4131 | Mechanism of action |
| Platelet adhesion inhibitor | 0.94 | 834 | Mechanism of action |
| Platelet aggregation inhibitor | 0.93 | 14493 | Mechanism of action |
| Platelet antagonist | 0.93 | 7340 | Mechanism of action |
| Platelet growth factor antagonist | 0.98 | 1070 | Mechanism of action |
| Polo-like kinase-1 inhibitor | 0.97 | 1805 | Mechanism of action |
| Polo-like kinase-2 inhibitor | 0.98 | 254 | Mechanism of action |
| Polo-like kinase-3 inhibitor | 0.94 | 393 | Mechanism of action |
| Polo-like kinase-4 inhibitor | 0.97 | 816 | Mechanism of action |
| Poly(ADP-ribose) polymerase 1 inhibitor | 0.99 | 3841 | Mechanism of action |
| Poly(ADP-ribose) polymerase 2 inhibitor | 1.0 | 366 | Mechanism of action |
| Poly(ADP-ribose) polymerase inhibitor | 0.99 | 4576 | Mechanism of action |
| Porphobilinogen synthase inhibitor | 0.99 | 26 | Mechanism of action |
| Potassium channel (ATP-sensitive) activator | 0.99 | 535 | Mechanism of action |
| Potassium channel (ATP-sensitive) blocker | 0.98 | 793 | Mechanism of action |
| Potassium channel (Ca-activated) activator | 0.97 | 374 | Mechanism of action |
| Potassium channel (Ca-activated) blocker | 0.98 | 554 | Mechanism of action |
| Potassium channel (Inward rectifier) 1 blocker | 0.99 | 1018 | Mechanism of action |
| Potassium channel (Inward rectifier) 11 blocker | 1.0 | 178 | Mechanism of action |
| Potassium channel (Inward rectifier) activator | 0.99 | 537 | Mechanism of action |
| Potassium channel (Inward rectifier) blocker | 0.99 | 1970 | Mechanism of action |
| Potassium channel (Voltage-sensitive) activator | 0.97 | 616 | Mechanism of action |
| Potassium channel (Voltage-sensitive) blocker | 0.93 | 8464 | Mechanism of action |
| Potassium channel KCNQ activator | 0.99 | 516 | Mechanism of action |
| Potassium channel Kv1.1 blocker | 0.99 | 153 | Mechanism of action |
| Potassium channel Kv1.3 blocker | 0.99 | 436 | Mechanism of action |
| Potassium channel Kv1.5 blocker | 0.98 | 966 | Mechanism of action |
| Potassium channel activator | 0.97 | 2989 | Mechanism of action |
| Potassium channel blocker | 0.93 | 13789 | Mechanism of action |
| Potassium channel intermediate-conductance Ca-activated blocker | 0.99 | 124 | Mechanism of action |
| Potassium channel large-conductance Ca-activated activator | 0.98 | 296 | Mechanism of action |
| Potassium channel small-conductance Ca-activated activator | 1.0 | 56 | Mechanism of action |
| Potassium channel small-conductance Ca-activated blocker | 0.98 | 360 | Mechanism of action |
| Pregnane X receptor agonist | 0.95 | 158 | Mechanism of action |
| Pregnane X receptor antagonist | 0.99 | 63 | Mechanism of action |
| Progesterone agonist | 1.0 | 636 | Mechanism of action |
| Progesterone antagonist | 0.99 | 2046 | Mechanism of action |
| Progesterone receptor A antagonist | 1.0 | 98 | Mechanism of action |
| Progesterone receptor B antagonist | 1.0 | 66 | Mechanism of action |
| Prokineticin receptor 1 antagonist | 1.0 | 597 | Mechanism of action |
| Prolactin inhibitor | 0.98 | 44 | Mechanism of action |
| Prolactin release inhibitor | 0.97 | 65 | Mechanism of action |
| Prolyl endopeptidase inhibitor | 0.99 | 964 | Mechanism of action |
| Prostacyclin agonist | 1.0 | 458 | Mechanism of action |
| Prostacyclin antagonist | 1.0 | 437 | Mechanism of action |
| Prostaglandin D2 agonist | 1.0 | 130 | Mechanism of action |
| Prostaglandin D2 antagonist | 1.0 | 3858 | Mechanism of action |
| Prostaglandin E2 agonist | 1.0 | 1613 | Mechanism of action |
| Prostaglandin E2 antagonist | 0.99 | 3473 | Mechanism of action |
| Prostaglandin EP1 antagonist | 1.0 | 872 | Mechanism of action |
| Prostaglandin EP2 agonist | 1.0 | 421 | Mechanism of action |
| Prostaglandin EP2 antagonist | 0.99 | 505 | Mechanism of action |
| Prostaglandin EP3 antagonist | 1.0 | 767 | Mechanism of action |
| Prostaglandin EP4 agonist | 1.0 | 476 | Mechanism of action |
| Prostaglandin EP4 antagonist | 1.0 | 916 | Mechanism of action |
| Prostaglandin F2 alpha agonist | 0.99 | 141 | Mechanism of action |
| Prostaglandin F2 alpha antagonist | 0.99 | 138 | Mechanism of action |
| Prostaglandin H2 antagonist | 1.0 | 380 | Mechanism of action |
| Prostaglandin agonist | 0.99 | 1973 | Mechanism of action |
| Prostaglandin antagonist | 0.99 | 7793 | Mechanism of action |
| Prostaglandin dehydrogenase inhibitor | 0.9 | 3162 | Mechanism of action |
| Prostaglandin-E synthase inhibitor | 0.99 | 1739 | Mechanism of action |
| Protease (Human cytomegalovirus) inhibitor | 1.0 | 150 | Mechanism of action |
| Protease 3C (Human rhinovirus) inhibitor | 0.98 | 222 | Mechanism of action |
| Protease activated receptor 1 agonist | 1.0 | 139 | Mechanism of action |
| Protease activated receptor 1 antagonist | 0.99 | 1113 | Mechanism of action |
| Protease activated receptor agonist | 1.0 | 317 | Mechanism of action |
| Protease activated receptor antagonist | 0.99 | 2241 | Mechanism of action |
| Protease inhibitor | 0.97 | 2485 | Mechanism of action |
| Proteasome inhibitor | 0.96 | 1545 | Mechanism of action |
| Protein 30S ribosomal subunit inhibitor | 0.99 | 385 | Mechanism of action |
| Protein 50S ribosomal subunit inhibitor | 0.99 | 145 | Mechanism of action |
| Protein kinase (CK1) delta inhibitor | 0.97 | 874 | Mechanism of action |
| Protein kinase (CK1) epsilon inhibitor | 0.99 | 550 | Mechanism of action |
| Protein kinase (CK1) gamma 1 inhibitor | 0.96 | 214 | Mechanism of action |
| Protein kinase (CK1) gamma 2 inhibitor | 0.97 | 271 | Mechanism of action |
| Protein kinase (CK1) gamma 3 inhibitor | 0.95 | 167 | Mechanism of action |
| Protein kinase (CK1) gamma inhibitor | 0.96 | 330 | Mechanism of action |
| Protein kinase (CK1) inhibitor | 0.96 | 1501 | Mechanism of action |
| Protein kinase (CK2) alpha inhibitor | 0.97 | 1149 | Mechanism of action |
| Protein kinase (CK2) beta inhibitor | 0.99 | 404 | Mechanism of action |
| Protein kinase (CK2) inhibitor | 0.98 | 1894 | Mechanism of action |
| Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.98 | 4077 | Mechanism of action |
| Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.98 | 7903 | Mechanism of action |
| Protein kinase A inhibitor | 0.98 | 1871 | Mechanism of action |
| Protein kinase B alpha inhibitor | 0.98 | 3240 | Mechanism of action |
| Protein kinase B beta inhibitor | 0.98 | 1361 | Mechanism of action |
| Protein kinase B gamma inhibitor | 0.98 | 774 | Mechanism of action |
| Protein kinase C alpha inhibitor | 0.98 | 2043 | Mechanism of action |
| Protein kinase C beta I inhibitor | 0.99 | 284 | Mechanism of action |
| Protein kinase C beta II inhibitor | 0.99 | 572 | Mechanism of action |
| Protein kinase C beta inhibitor | 0.98 | 1290 | Mechanism of action |
| Protein kinase C delta inhibitor | 0.97 | 1481 | Mechanism of action |
| Protein kinase C epsilon inhibitor | 0.99 | 1231 | Mechanism of action |
| Protein kinase C eta inhibitor | 0.99 | 559 | Mechanism of action |
| Protein kinase C gamma inhibitor | 0.97 | 786 | Mechanism of action |
| Protein kinase C iota inhibitor | 0.98 | 733 | Mechanism of action |
| Protein kinase C mu inhibitor | 0.97 | 297 | Mechanism of action |
| Protein kinase C nu inhibitor | 0.95 | 562 | Mechanism of action |
| Protein kinase C theta inhibitor | 0.99 | 3257 | Mechanism of action |
| Protein kinase C zeta inhibitor | 0.97 | 430 | Mechanism of action |
| Protein kinase stimulant | 0.95 | 267 | Mechanism of action |
| Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.97 | 4092 | Mechanism of action |
| Protein-tyrosine kinase Lyn inhibitor | 0.96 | 912 | Mechanism of action |
| Protein-tyrosine phosphatase 1B inhibitor | 0.97 | 3163 | Mechanism of action |
| Protein-tyrosine phosphatase inhibitor | 0.95 | 4823 | Mechanism of action |
| Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.92 | 884 | Mechanism of action |
| Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.98 | 3516 | Mechanism of action |
| Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.99 | 4740 | Mechanism of action |
| Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.96 | 241 | Mechanism of action |
| Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.98 | 475 | Mechanism of action |
| Protocollagen prolyl hydroxylase inhibitor | 0.99 | 1139 | Mechanism of action |
| Psychostimulant | 0.95 | 432 | Mechanism of action |
| Purine nucleoside phosphorylase inhibitor | 1.0 | 461 | Mechanism of action |
| Purinergic P2 agonist | 1.0 | 520 | Mechanism of action |
| Purinergic P2 antagonist | 0.98 | 7578 | Mechanism of action |
| Purinergic P2T antagonist | 1.0 | 256 | Mechanism of action |
| Purinergic P2X agonist | 1.0 | 25 | Mechanism of action |
| Purinergic P2X antagonist | 0.99 | 5317 | Mechanism of action |
| Purinergic P2X1 antagonist | 0.98 | 58 | Mechanism of action |
| Purinergic P2X2 antagonist | 0.99 | 95 | Mechanism of action |
| Purinergic P2X3 antagonist | 0.99 | 1671 | Mechanism of action |
| Purinergic P2X4 antagonist | 0.99 | 116 | Mechanism of action |
| Purinergic P2X7 antagonist | 0.99 | 2566 | Mechanism of action |
| Purinergic P2Y agonist | 1.0 | 503 | Mechanism of action |
| Purinergic P2Y antagonist | 0.99 | 2278 | Mechanism of action |
| Purinergic P2Y1 agonist | 0.99 | 102 | Mechanism of action |
| Purinergic P2Y1 antagonist | 1.0 | 523 | Mechanism of action |
| Purinergic P2Y12 antagonist | 1.0 | 1096 | Mechanism of action |
| Purinergic P2Y14 antagonist | 1.0 | 125 | Mechanism of action |
| Purinergic P2Y15 antagonist | 1.0 | 30 | Mechanism of action |
| Purinergic P2Y2 agonist | 1.0 | 201 | Mechanism of action |
| Purinergic P2Y2 antagonist | 0.99 | 91 | Mechanism of action |
| Purinergic P2Y4 agonist | 1.0 | 97 | Mechanism of action |
| Purinergic P2Y6 agonist | 1.0 | 170 | Mechanism of action |
| Purinergic receptor agonist | 1.0 | 520 | Mechanism of action |
| Pyruvate kinase inhibitor | 0.94 | 660 | Mechanism of action |
| RET inhibitor | 0.96 | 1564 | Mechanism of action |
| RNA-directed RNA polymerase inhibitor | 0.99 | 1188 | Mechanism of action |
| RNA-directed RNA polymerase stimulant | 1.0 | 7 | Mechanism of action |
| Raf kinase B inhibitor | 0.99 | 5728 | Mechanism of action |
| Raf kinase C inhibitor | 0.99 | 1382 | Mechanism of action |
| Raf kinase inhibitor | 0.98 | 6920 | Mechanism of action |
| Renin inhibitor | 1.0 | 5255 | Mechanism of action |
| Retinoic acid alpha receptor agonist | 0.99 | 118 | Mechanism of action |
| Retinoic acid alpha receptor antagonist | 1.0 | 285 | Mechanism of action |
| Retinoic acid beta receptor agonist | 1.0 | 144 | Mechanism of action |
| Retinoic acid beta receptor antagonist | 1.0 | 277 | Mechanism of action |
| Retinoic acid gamma receptor agonist | 1.0 | 110 | Mechanism of action |
| Retinoic acid receptor agonist | 1.0 | 356 | Mechanism of action |
| Retinoic acid receptor antagonist | 1.0 | 436 | Mechanism of action |
| Retinoic acid receptor gamma antagonist | 1.0 | 296 | Mechanism of action |
| Retinoid X alpha receptor agonist | 0.99 | 216 | Mechanism of action |
| Retinoid X alpha receptor antagonist | 0.99 | 324 | Mechanism of action |
| Retinoid X beta receptor agonist | 1.0 | 102 | Mechanism of action |
| Retinoid X beta receptor antagonist | 1.0 | 120 | Mechanism of action |
| Retinoid X gamma receptor agonist | 1.0 | 102 | Mechanism of action |
| Retinoid X gamma receptor antagonist | 1.0 | 135 | Mechanism of action |
| Retinoid X receptor agonist | 1.0 | 388 | Mechanism of action |
| Retinoid X receptor antagonist | 0.99 | 338 | Mechanism of action |
| Rho-associated kinase I inhibitor | 0.98 | 3479 | Mechanism of action |
| Rho-associated kinase II inhibitor | 0.98 | 3789 | Mechanism of action |
| Rho-associated kinase inhibitor | 0.98 | 6222 | Mechanism of action |
| Ribonucleotide reductase inhibitor | 0.99 | 389 | Mechanism of action |
| Ribosomal protein S6 kinase inhibitor | 0.96 | 2221 | Mechanism of action |
| Ryanodine receptor antagonist | 0.98 | 87 | Mechanism of action |
| S-adenosyl-L-homocysteine hydrolase inhibitor | 0.99 | 250 | Mechanism of action |
| S-adenosyl-L-methionine decarboxylase inhibitor | 0.98 | 77 | Mechanism of action |
| Secretase beta inhibitor | 0.98 | 8842 | Mechanism of action |
| Secretase gamma inhibitor | 0.99 | 2770 | Mechanism of action |
| Selectin antagonist | 0.98 | 507 | Mechanism of action |
| Sigma 1 receptor antagonist | 1.0 | 1058 | Mechanism of action |
| Sigma 2 receptor antagonist | 1.0 | 585 | Mechanism of action |
| Sigma receptor agonist | 0.96 | 26 | Mechanism of action |
| Sigma receptor antagonist | 0.99 | 2242 | Mechanism of action |
| Sirtuin 1 inhibitor | 0.99 | 143 | Mechanism of action |
| Sirtuin 2 inhibitor | 1.0 | 189 | Mechanism of action |
| Smo receptor antagonist | 0.99 | 690 | Mechanism of action |
| Sodium channel (voltage-gated) blocker | 0.96 | 8520 | Mechanism of action |
| Sodium channel blocker | 0.96 | 11475 | Mechanism of action |
| Sodium/bile acid cotransporter inhibitor | 0.91 | 28 | Mechanism of action |
| Sodium/calcium exchanger inhibitor | 0.98 | 146 | Mechanism of action |
| Sodium/glucose cotransporter 2 inhibitor | 1.0 | 2061 | Mechanism of action |
| Sodium/glucose cotransporter inhibitor | 0.99 | 2679 | Mechanism of action |
| Sodium/hydrogen exchanger inhibitor | 1.0 | 1360 | Mechanism of action |
| Somatostatin 1 agonist | 0.99 | 18 | Mechanism of action |
| Somatostatin 1 antagonist | 0.99 | 389 | Mechanism of action |
| Somatostatin 2 agonist | 1.0 | 156 | Mechanism of action |
| Somatostatin 2 antagonist | 0.99 | 573 | Mechanism of action |
| Somatostatin 3 agonist | 1.0 | 102 | Mechanism of action |
| Somatostatin 3 antagonist | 0.99 | 624 | Mechanism of action |
| Somatostatin 4 agonist | 0.99 | 84 | Mechanism of action |
| Somatostatin 4 antagonist | 0.99 | 430 | Mechanism of action |
| Somatostatin 5 agonist | 1.0 | 37 | Mechanism of action |
| Somatostatin 5 antagonist | 1.0 | 753 | Mechanism of action |
| Somatostatin agonist | 0.99 | 395 | Mechanism of action |
| Spasmolytic | 0.92 | 2281 | Mechanism of action |
| Sphingomyelinase inhibitor | 0.97 | 104 | Mechanism of action |
| Sphingosine 1-phosphate receptor 1 agonist | 0.99 | 2739 | Mechanism of action |
| Sphingosine 1-phosphate receptor 1 antagonist | 0.98 | 1093 | Mechanism of action |
| Sphingosine 1-phosphate receptor 2 agonist | 0.95 | 34 | Mechanism of action |
| Sphingosine 1-phosphate receptor 2 antagonist | 0.95 | 234 | Mechanism of action |
| Sphingosine 1-phosphate receptor 3 agonist | 1.0 | 628 | Mechanism of action |
| Sphingosine 1-phosphate receptor 3 antagonist | 0.99 | 451 | Mechanism of action |
| Sphingosine 1-phosphate receptor 4 agonist | 0.99 | 186 | Mechanism of action |
| Sphingosine 1-phosphate receptor 4 antagonist | 0.95 | 283 | Mechanism of action |
| Sphingosine 1-phosphate receptor 5 agonist | 0.99 | 297 | Mechanism of action |
| Sphingosine 1-phosphate receptor 5 antagonist | 0.94 | 224 | Mechanism of action |
| Sphingosine 1-phosphate receptor agonist | 0.99 | 3672 | Mechanism of action |
| Sphingosine 1-phosphate receptor antagonist | 0.98 | 1596 | Mechanism of action |
| Sphingosine kinase 1 inhibitor | 0.99 | 311 | Mechanism of action |
| Sphingosine kinase 2 inhibitor | 0.99 | 173 | Mechanism of action |
| Sphingosine kinase inhibitor | 0.99 | 353 | Mechanism of action |
| Squalene epoxidase inhibitor | 0.99 | 209 | Mechanism of action |
| Squalene synthetase inhibitor | 1.0 | 1323 | Mechanism of action |
| Src kinase inhibitor | 0.95 | 9395 | Mechanism of action |
| Stearoyl-CoA desaturase inhibitor | 0.99 | 1403 | Mechanism of action |
| Stem cell growth factor agonist | 0.98 | 205 | Mechanism of action |
| Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 1.0 | 1032 | Mechanism of action |
| Streptokinase A inhibitor | 0.91 | 2253 | Mechanism of action |
| Substance P antagonist | 0.99 | 3146 | Mechanism of action |
| Succinate dehydrogenase inhibitor | 0.95 | 30 | Mechanism of action |
| Superoxide dismutase inhibitor | 0.92 | 53 | Mechanism of action |
| Syk tyrosine kinase inhibitor | 0.98 | 4016 | Mechanism of action |
| T cell inhibitor | 0.96 | 262 | Mechanism of action |
| TIE antagonist | 0.98 | 2130 | Mechanism of action |
| TIE-2 antagonist | 0.98 | 2099 | Mechanism of action |
| TRKA antagonist | 0.96 | 1514 | Mechanism of action |
| TRKB antagonist | 0.96 | 911 | Mechanism of action |
| TRKC antagonist | 0.95 | 462 | Mechanism of action |
| TRPA1 agonist | 0.96 | 179 | Mechanism of action |
| TRPA1 antagonist | 0.99 | 914 | Mechanism of action |
| TRPM8 blocker | 0.99 | 915 | Mechanism of action |
| Telomerase inhibitor | 0.97 | 1110 | Mechanism of action |
| Telomerase stimulant | 1.0 | 11 | Mechanism of action |
| Thiazolidinedione | 1.0 | 26 | Mechanism of action |
| Thiol protease inhibitor | 0.94 | 849 | Mechanism of action |
| Thioredoxin glutathione reductase inhibitor | 0.9 | 5616 | Mechanism of action |
| Thioredoxin inhibitor | 0.97 | 222 | Mechanism of action |
| Thioredoxin reductase inhibitor | 0.97 | 251 | Mechanism of action |
| Thrombin inhibitor | 0.98 | 7047 | Mechanism of action |
| Thrombin receptor antagonist | 0.99 | 174 | Mechanism of action |
| Thrombolytic | 0.95 | 1171 | Mechanism of action |
| Thrombopoietin agonist | 1.0 | 319 | Mechanism of action |
| Thromboxane A2 antagonist | 0.99 | 1690 | Mechanism of action |
| Thromboxane agonist | 1.0 | 69 | Mechanism of action |
| Thromboxane antagonist | 0.99 | 1906 | Mechanism of action |
| Thromboxane synthase inhibitor | 0.99 | 1804 | Mechanism of action |
| Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.99 | 146 | Mechanism of action |
| Thymidine kinase (Herpes simplex virus 2) inhibitor | 1.0 | 128 | Mechanism of action |
| Thymidine kinase inhibitor | 0.99 | 410 | Mechanism of action |
| Thymidine phosphorylase inhibitor | 0.99 | 242 | Mechanism of action |
| Thymidylate synthase inhibitor | 0.99 | 1701 | Mechanism of action |
| Thyroid hormone agonist | 0.99 | 295 | Mechanism of action |
| Thyroid hormone alpha agonist | 1.0 | 60 | Mechanism of action |
| Thyroid hormone alpha antagonist | 1.0 | 235 | Mechanism of action |
| Thyroid hormone antagonist | 0.9 | 2286 | Mechanism of action |
| Thyroid hormone beta agonist | 1.0 | 240 | Mechanism of action |
| Thyroid hormone beta antagonist | 0.9 | 2179 | Mechanism of action |
| Toll-Like receptor 2 agonist | 0.99 | 73 | Mechanism of action |
| Toll-Like receptor 2 antagonist | 0.96 | 82 | Mechanism of action |
| Toll-Like receptor 4 agonist | 0.99 | 83 | Mechanism of action |
| Toll-Like receptor 4 antagonist | 0.97 | 123 | Mechanism of action |
| Toll-Like receptor 7 agonist | 0.88 | 20585 | Mechanism of action |
| Toll-Like receptor 7 antagonist | 0.98 | 375 | Mechanism of action |
| Toll-Like receptor 8 agonist | 0.99 | 334 | Mechanism of action |
| Toll-Like receptor 8 antagonist | 0.99 | 408 | Mechanism of action |
| Toll-Like receptor 9 antagonist | 0.96 | 395 | Mechanism of action |
| Toll-Like receptor agonist | 0.88 | 20866 | Mechanism of action |
| Toll-Like receptor antagonist | 0.96 | 1028 | Mechanism of action |
| Topoisomerase I inhibitor | 0.97 | 1704 | Mechanism of action |
| Topoisomerase II alpha inhibitor | 0.98 | 554 | Mechanism of action |
| Topoisomerase II beta inhibitor | 0.98 | 142 | Mechanism of action |
| Topoisomerase II inhibitor | 0.96 | 1920 | Mechanism of action |
| Transcortin receptor antagonist | 1.0 | 29 | Mechanism of action |
| Transcription factor AP-1 inhibitor | 0.98 | 437 | Mechanism of action |
| Transcription factor NF kappa B inhibitor | 0.89 | 1692 | Mechanism of action |
| Transcription factor NF kappa B stimulant | 0.97 | 52 | Mechanism of action |
| Transcription factor RelA inhibitor | 0.97 | 72 | Mechanism of action |
| Transcription factor STAT inhibitor | 0.91 | 1167 | Mechanism of action |
| Transcription factor STAT3 inhibitor | 0.91 | 881 | Mechanism of action |
| Transcription factor STAT6 inhibitor | 0.95 | 247 | Mechanism of action |
| Transcription factor inhibitor | 0.86 | 25498 | Mechanism of action |
| Transforming growth factor antagonist | 0.98 | 2168 | Mechanism of action |
| Transforming growth factor beta 1 antagonist | 0.99 | 1925 | Mechanism of action |
| Transforming growth factor beta 2 antagonist | 0.99 | 152 | Mechanism of action |
| Transforming growth factor beta 3 antagonist | 0.96 | 75 | Mechanism of action |
| Triose-phosphate isomerase inhibitor | 0.97 | 30 | Mechanism of action |
| Trypsin I inhibitor | 0.99 | 1693 | Mechanism of action |
| Trypsin II inhibitor | 1.0 | 189 | Mechanism of action |
| Trypsin inhibitor | 0.97 | 3410 | Mechanism of action |
| Tryptase inhibitor | 0.99 | 701 | Mechanism of action |
| Tryptophan 5 hydroxylase inhibitor | 0.99 | 322 | Mechanism of action |
| Tryptophan hydroxylase 1 inhibitor | 0.99 | 291 | Mechanism of action |
| Tubulin agonist | 1.0 | 33 | Mechanism of action |
| Tubulin antagonist | 0.96 | 3491 | Mechanism of action |
| Tumour necrosis factor alpha release inhibitor | 0.92 | 3753 | Mechanism of action |
| Tumour necrosis factor antagonist | 0.93 | 1361 | Mechanism of action |
| Tyk2 inhibitor | 0.99 | 2342 | Mechanism of action |
| Tyrosine 3 hydroxylase inhibitor | 0.91 | 12 | Mechanism of action |
| Tyrosine kinase inhibitor | 0.94 | 44120 | Mechanism of action |
| Tyrosine-protein kinase EMT inhibitor | 0.99 | 2245 | Mechanism of action |
| Tyrosine-protein kinase receptor FLT3 inhibitor | 0.97 | 4747 | Mechanism of action |
| Tyrosine-protein kinase receptor antagonist | 0.96 | 2007 | Mechanism of action |
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.97 | 25 | Mechanism of action |
| UDP-glucose 4-epimerase inhibitor | 0.98 | 31 | Mechanism of action |
| Urate transporter 1 inhibitor | 0.99 | 421 | Mechanism of action |
| Urease inhibitor | 0.97 | 371 | Mechanism of action |
| Uric acid excretion stimulant | 0.97 | 913 | Mechanism of action |
| Uridine phosphorylase inhibitor | 1.0 | 130 | Mechanism of action |
| Urokinase inhibitor | 0.99 | 1287 | Mechanism of action |
| Urotensin II agonist | 1.0 | 200 | Mechanism of action |
| Urotensin II antagonist | 1.0 | 802 | Mechanism of action |
| VCAM antagonist | 0.99 | 442 | Mechanism of action |
| VCAM-1 antagonist | 0.99 | 441 | Mechanism of action |
| VLA-4 antagonist | 1.0 | 1120 | Mechanism of action |
| Vanilloid 1 agonist | 0.94 | 170 | Mechanism of action |
| Vanilloid 1 antagonist | 0.98 | 1512 | Mechanism of action |
| Vanilloid 2 antagonist | 0.98 | 102 | Mechanism of action |
| Vanilloid 3 antagonist | 0.99 | 79 | Mechanism of action |
| Vanilloid 4 agonist | 0.97 | 38 | Mechanism of action |
| Vanilloid 4 antagonist | 0.99 | 616 | Mechanism of action |
| Vanilloid agonist | 0.96 | 347 | Mechanism of action |
| Vanilloid antagonist | 0.98 | 3962 | Mechanism of action |
| Vascular adhesion protein 1 inhibitor | 1.0 | 356 | Mechanism of action |
| Vascular endothelial growth factor 1 antagonist | 0.97 | 2240 | Mechanism of action |
| Vascular endothelial growth factor 2 antagonist | 0.97 | 16055 | Mechanism of action |
| Vascular endothelial growth factor 3 antagonist | 0.96 | 1336 | Mechanism of action |
| Vascular endothelial growth factor antagonist | 0.96 | 17097 | Mechanism of action |
| Vasodilator | 0.92 | 2295 | Mechanism of action |
| Vasodilator, coronary | 0.89 | 292 | Mechanism of action |
| Vasodilator, peripheral | 0.89 | 225 | Mechanism of action |
| Vasopressin 1 agonist | 0.99 | 283 | Mechanism of action |
| Vasopressin 1 antagonist | 1.0 | 1926 | Mechanism of action |
| Vasopressin 1A agonist | 0.99 | 152 | Mechanism of action |
| Vasopressin 1A antagonist | 1.0 | 1578 | Mechanism of action |
| Vasopressin 1B agonist | 1.0 | 206 | Mechanism of action |
| Vasopressin 1B antagonist | 1.0 | 525 | Mechanism of action |
| Vasopressin 2 agonist | 1.0 | 427 | Mechanism of action |
| Vasopressin 2 antagonist | 0.99 | 1114 | Mechanism of action |
| Vitamin D receptor agonist | 1.0 | 257 | Mechanism of action |
| Vitamin D receptor antagonist | 0.99 | 283 | Mechanism of action |
| Vitamin D-like | 1.0 | 170 | Mechanism of action |
| Vitronectin receptor antagonist | 1.0 | 1896 | Mechanism of action |
| Xanthine dehydrogenase inhibitor | 0.99 | 941 | Mechanism of action |
| Xanthine oxidase inhibitor | 0.96 | 686 | Mechanism of action |
| ZAP-70 protein tyrosine kinase inhibitor | 0.98 | 966 | Mechanism of action |
| c-Src kinase inhibitor | 0.97 | 4808 | Mechanism of action |
| mTOR complex 1 inhibitor | 0.96 | 297 | Mechanism of action |
| mTOR complex 2 inhibitor | 0.97 | 105 | Mechanism of action |
| mTOR inhibitor | 0.99 | 7995 | Mechanism of action |
| p38 MAP kinase inhibitor | 0.98 | 1616 | Mechanism of action |
| p53 inhibitor | 0.99 | 789 | Mechanism of action |
| Acaricide | 0.96 | 53 | Pharmacological effect |
| Acetylcholine release stimulant | 0.96 | 154 | Pharmacological effect |
| Actinic keratosis treatment | 0.97 | 211 | Pharmacological effect |
| Acute neurologic disorders treatment | 0.92 | 5466 | Pharmacological effect |
| Acute respiratory distress syndrome (ARDS) treatment | 0.94 | 1416 | Pharmacological effect |
| Age-related macular degeneration treatment | 0.91 | 116 | Pharmacological effect |
| Allergic rhinitis treatment | 0.95 | 2759 | Pharmacological effect |
| Alzheimer's disease treatment | 0.85 | 23489 | Pharmacological effect |
| Amyotrophic lateral sclerosis treatment | 0.91 | 2354 | Pharmacological effect |
| Anabolic | 0.97 | 185 | Pharmacological effect |
| Analeptic | 0.92 | 270 | Pharmacological effect |
| Analgesic | 0.86 | 33470 | Pharmacological effect |
| Analgesic, non-opioid | 0.87 | 21427 | Pharmacological effect |
| Analgesic, opioid | 0.98 | 3646 | Pharmacological effect |
| Andropause treatment | 0.97 | 90 | Pharmacological effect |
| Anesthetic | 0.96 | 1392 | Pharmacological effect |
| Anesthetic general | 0.95 | 226 | Pharmacological effect |
| Anesthetic inhalation | 0.99 | 27 | Pharmacological effect |
| Anesthetic local | 0.97 | 620 | Pharmacological effect |
| Angiogenesis inhibitor | 0.89 | 9144 | Pharmacological effect |
| Angiogenesis stimulant | 0.94 | 142 | Pharmacological effect |
| Ankylosing spondylitis treatment | 0.98 | 889 | Pharmacological effect |
| Antiacne | 0.96 | 2456 | Pharmacological effect |
| Antialcoholic | 0.93 | 525 | Pharmacological effect |
| Antiallergic | 0.89 | 14837 | Pharmacological effect |
| Antiamyloidogenic | 0.93 | 3286 | Pharmacological effect |
| Antianemic | 0.95 | 1333 | Pharmacological effect |
| Antianginal | 0.95 | 3717 | Pharmacological effect |
| Antianorexic | 0.95 | 213 | Pharmacological effect |
| Antiarrhythmic | 0.93 | 4748 | Pharmacological effect |
| Antiarthritic | 0.86 | 21906 | Pharmacological effect |
| Antiasthmatic | 0.88 | 19967 | Pharmacological effect |
| Antibacterial | 0.87 | 47866 | Pharmacological effect |
| Antibiotic | 0.98 | 10654 | Pharmacological effect |
| Antibiotic Aminoglycoside-like | 0.99 | 93 | Pharmacological effect |
| Antibiotic Anthracycline-like | 1.0 | 75 | Pharmacological effect |
| Antibiotic Carbacephem-like | 1.0 | 116 | Pharmacological effect |
| Antibiotic Carbapenem-like | 1.0 | 1146 | Pharmacological effect |
| Antibiotic Cephalosporin-like | 1.0 | 1617 | Pharmacological effect |
| Antibiotic Glycopeptide-like | 0.99 | 148 | Pharmacological effect |
| Antibiotic Macrolide-like | 1.0 | 1008 | Pharmacological effect |
| Antibiotic Naphthyridine-like | 0.98 | 52 | Pharmacological effect |
| Antibiotic Oxazolidinone-like | 1.0 | 160 | Pharmacological effect |
| Antibiotic Penem-like | 1.0 | 211 | Pharmacological effect |
| Antibiotic Penicillin-like | 1.0 | 174 | Pharmacological effect |
| Antibiotic Quinolone-like | 0.99 | 511 | Pharmacological effect |
| Antibiotic Rifamycin-like | 1.0 | 65 | Pharmacological effect |
| Antibiotic Tetracycline-like | 0.99 | 35 | Pharmacological effect |
| Antibiotic Tribactam-like | 1.0 | 77 | Pharmacological effect |
| Antibiotic Trimethoprim-like | 1.0 | 11 | Pharmacological effect |
| Antibiotic beta Lactam-like | 1.0 | 3694 | Pharmacological effect |
| Anticataract | 0.97 | 665 | Pharmacological effect |
| Anticholelithogenic | 0.98 | 145 | Pharmacological effect |
| Anticoagulant | 0.95 | 9613 | Pharmacological effect |
| Anticonvulsant | 0.94 | 4690 | Pharmacological effect |
| Antidepressant | 0.9 | 19174 | Pharmacological effect |
| Antidiabetic | 0.85 | 42620 | Pharmacological effect |
| Antidiabetic (type 1) | 0.94 | 850 | Pharmacological effect |
| Antidiabetic (type 2) | 0.91 | 12088 | Pharmacological effect |
| Antidiabetic symptomatic | 0.91 | 4061 | Pharmacological effect |
| Antidiarrheal | 0.94 | 620 | Pharmacological effect |
| Antidote | 0.96 | 428 | Pharmacological effect |
| Antidote, heavy metal | 0.99 | 207 | Pharmacological effect |
| Antidote, mercury | 0.99 | 4 | Pharmacological effect |
| Antidote, organophosphates | 0.94 | 10 | Pharmacological effect |
| Antieczematic | 0.95 | 207 | Pharmacological effect |
| Antieczematic atopic | 0.93 | 2514 | Pharmacological effect |
| Antiemetic | 0.97 | 2187 | Pharmacological effect |
| Antiemphysemic | 0.98 | 828 | Pharmacological effect |
| Antiepileptic | 0.91 | 8667 | Pharmacological effect |
| Antifibrinolytic | 0.96 | 584 | Pharmacological effect |
| Antifungal | 0.9 | 11571 | Pharmacological effect |
| Antifungal (Aspergillus) | 0.96 | 192 | Pharmacological effect |
| Antifungal (Candida) | 0.96 | 350 | Pharmacological effect |
| Antifungal (Cryptococcus) | 0.93 | 48 | Pharmacological effect |
| Antifungal (Pneumocystis) | 0.92 | 15 | Pharmacological effect |
| Antifungal enhancer | 0.95 | 98 | Pharmacological effect |
| Antiglaucomic | 0.93 | 5281 | Pharmacological effect |
| Antihelmintic | 0.94 | 1826 | Pharmacological effect |
| Antihelmintic (Fasciola) | 0.98 | 12 | Pharmacological effect |
| Antihelmintic (Nematodes) | 0.95 | 197 | Pharmacological effect |
| Antihelmintic (Trematoda) | 0.95 | 153 | Pharmacological effect |
| Antihemophilic | 0.98 | 79 | Pharmacological effect |
| Antihemorrhagic | 0.96 | 30 | Pharmacological effect |
| Antihyperaldosteronism | 1.0 | 301 | Pharmacological effect |
| Antihypercholesterolemic | 0.92 | 312 | Pharmacological effect |
| Antihyperlipoproteinemic | 0.96 | 152 | Pharmacological effect |
| Antihypermotility | 0.96 | 133 | Pharmacological effect |
| Antihypertensive | 0.9 | 20869 | Pharmacological effect |
| Antihypertriglyceridemic | 0.92 | 875 | Pharmacological effect |
| Antihypotensive | 0.92 | 91 | Pharmacological effect |
| Antihypoxic | 0.9 | 138 | Pharmacological effect |
| Antiinfertility, female | 0.96 | 292 | Pharmacological effect |
| Antiinflammatory | 0.82 | 38424 | Pharmacological effect |
| Antiischemic | 0.91 | 8426 | Pharmacological effect |
| Antiischemic, cerebral | 0.95 | 2248 | Pharmacological effect |
| Antileprosy | 0.96 | 162 | Pharmacological effect |
| Antileukemic | 0.9 | 19289 | Pharmacological effect |
| Antimetabolite | 0.99 | 946 | Pharmacological effect |
| Antimigraine | 0.94 | 3724 | Pharmacological effect |
| Antimitotic | 0.93 | 7085 | Pharmacological effect |
| Antimutagenic | 0.97 | 40 | Pharmacological effect |
| Antimycobacterial | 0.9 | 7390 | Pharmacological effect |
| Antimycoplasmal | 0.98 | 174 | Pharmacological effect |
| Antineoplastic (bladder cancer) | 0.89 | 781 | Pharmacological effect |
| Antineoplastic (bone cancer) | 0.93 | 407 | Pharmacological effect |
| Antineoplastic (brain cancer) | 0.88 | 1381 | Pharmacological effect |
| Antineoplastic (breast cancer) | 0.88 | 28293 | Pharmacological effect |
| Antineoplastic (carcinoma) | 0.95 | 4841 | Pharmacological effect |
| Antineoplastic (cervical cancer) | 0.93 | 9561 | Pharmacological effect |
| Antineoplastic (colon cancer) | 0.92 | 24176 | Pharmacological effect |
| Antineoplastic (colorectal cancer) | 0.91 | 25093 | Pharmacological effect |
| Antineoplastic (endocrine cancer) | 0.87 | 489 | Pharmacological effect |
| Antineoplastic (gastric cancer) | 0.93 | 2576 | Pharmacological effect |
| Antineoplastic (glioblastoma multiforme) | 0.93 | 3056 | Pharmacological effect |
| Antineoplastic (glioma) | 0.93 | 3906 | Pharmacological effect |
| Antineoplastic (insulinoma) | 1.0 | 44 | Pharmacological effect |
| Antineoplastic (liver cancer) | 0.91 | 2196 | Pharmacological effect |
| Antineoplastic (lung cancer) | 0.9 | 23853 | Pharmacological effect |
| Antineoplastic (lymphocytic leukemia) | 0.93 | 4728 | Pharmacological effect |
| Antineoplastic (lymphoma) | 0.92 | 1960 | Pharmacological effect |
| Antineoplastic (melanoma) | 0.91 | 5972 | Pharmacological effect |
| Antineoplastic (multiple myeloma) | 0.9 | 1610 | Pharmacological effect |
| Antineoplastic (myeloid leukemia) | 0.84 | 951 | Pharmacological effect |
| Antineoplastic (non-Hodgkin's lymphoma) | 0.86 | 462 | Pharmacological effect |
| Antineoplastic (non-small cell lung cancer) | 0.92 | 7441 | Pharmacological effect |
| Antineoplastic (osteosarcoma) | 0.88 | 532 | Pharmacological effect |
| Antineoplastic (ovarian cancer) | 0.91 | 8285 | Pharmacological effect |
| Antineoplastic (pancreatic cancer) | 0.9 | 2849 | Pharmacological effect |
| Antineoplastic (renal cancer) | 0.92 | 3404 | Pharmacological effect |
| Antineoplastic (sarcoma) | 0.89 | 866 | Pharmacological effect |
| Antineoplastic (small cell lung cancer) | 0.87 | 478 | Pharmacological effect |
| Antineoplastic (solid tumors) | 0.83 | 1361 | Pharmacological effect |
| Antineoplastic (squamous cell carcinoma) | 0.95 | 2806 | Pharmacological effect |
| Antineoplastic (uterine cancer) | 0.94 | 139 | Pharmacological effect |
| Antineoplastic alkaloid | 0.97 | 99 | Pharmacological effect |
| Antineoplastic antibiotic | 0.98 | 2909 | Pharmacological effect |
| Antineoplastic antimetabolite | 0.95 | 178 | Pharmacological effect |
| Antineoplastic enhancer | 0.91 | 1870 | Pharmacological effect |
| Antineoplastic, alkylator | 0.97 | 131 | Pharmacological effect |
| Antinephritic | 0.93 | 771 | Pharmacological effect |
| Antineurogenic pain | 0.91 | 3486 | Pharmacological effect |
| Antiobesity | 0.88 | 21578 | Pharmacological effect |
| Antiosteoporotic | 0.91 | 7542 | Pharmacological effect |
| Antioxidant | 0.92 | 4992 | Pharmacological effect |
| Antiparasitic | 0.93 | 2207 | Pharmacological effect |
| Antiparkinsonian | 0.86 | 12560 | Pharmacological effect |
| Antiparkinsonian, rigidity relieving | 0.95 | 39 | Pharmacological effect |
| Antiparkinsonian, tremor relieving | 0.96 | 118 | Pharmacological effect |
| Antiprotozoal | 0.87 | 36286 | Pharmacological effect |
| Antiprotozoal (Amoeba) | 0.95 | 477 | Pharmacological effect |
| Antiprotozoal (Babesia) | 0.99 | 6 | Pharmacological effect |
| Antiprotozoal (Coccidial) | 0.95 | 313 | Pharmacological effect |
| Antiprotozoal (Histomonas) | 1.0 | 8 | Pharmacological effect |
| Antiprotozoal (Leishmania) | 0.92 | 3453 | Pharmacological effect |
| Antiprotozoal (Plasmodium) | 0.88 | 25569 | Pharmacological effect |
| Antiprotozoal (Toxoplasma) | 0.97 | 338 | Pharmacological effect |
| Antiprotozoal (Trichomonas) | 0.95 | 335 | Pharmacological effect |
| Antiprotozoal (Trypanosoma) | 0.91 | 7555 | Pharmacological effect |
| Antiprotozoal activity enhancer | 0.99 | 30 | Pharmacological effect |
| Antipruritic | 0.94 | 1318 | Pharmacological effect |
| Antipruritic, allergic | 0.86 | 166 | Pharmacological effect |
| Antipruritic, non-allergic | 0.94 | 76 | Pharmacological effect |
| Antipsoriatic | 0.9 | 10270 | Pharmacological effect |
| Antipsychotic | 0.91 | 19186 | Pharmacological effect |
| Antipyretic | 0.92 | 718 | Pharmacological effect |
| Antirickettsial | 0.94 | 21 | Pharmacological effect |
| Antischistosomal | 0.98 | 56 | Pharmacological effect |
| Antiseptic | 0.97 | 262 | Pharmacological effect |
| Antismoking | 0.96 | 455 | Pharmacological effect |
| Antispirochetal | 0.97 | 36 | Pharmacological effect |
| Antithrombocytopenic | 0.95 | 441 | Pharmacological effect |
| Antithrombotic | 0.89 | 681 | Pharmacological effect |
| Antitreponemal | 0.94 | 12 | Pharmacological effect |
| Antituberculosic | 0.91 | 5762 | Pharmacological effect |
| Antitussive | 0.96 | 1005 | Pharmacological effect |
| Antiulcerative | 0.93 | 3295 | Pharmacological effect |
| Antiviral (Bovine viral diarrhea virus) | 0.99 | 313 | Pharmacological effect |
| Antiviral (CMV) | 0.94 | 574 | Pharmacological effect |
| Antiviral (HIV) | 0.92 | 33218 | Pharmacological effect |
| Antiviral (Hepatitis A) | 0.95 | 61 | Pharmacological effect |
| Antiviral (Hepatitis B) | 0.96 | 3523 | Pharmacological effect |
| Antiviral (Hepatitis C) | 0.94 | 14730 | Pharmacological effect |
| Antiviral (Hepatitis) | 0.94 | 18360 | Pharmacological effect |
| Antiviral (Herpes) | 0.94 | 2330 | Pharmacological effect |
| Antiviral (Herpesvirus 3, Human) | 0.98 | 333 | Pharmacological effect |
| Antiviral (Influenza A) | 0.94 | 1254 | Pharmacological effect |
| Antiviral (Influenza B) | 0.95 | 225 | Pharmacological effect |
| Antiviral (Influenza) | 0.93 | 3024 | Pharmacological effect |
| Antiviral (Papilloma) | 0.95 | 203 | Pharmacological effect |
| Antiviral (Parainfluenza) | 0.99 | 24 | Pharmacological effect |
| Antiviral (Poxvirus) | 0.97 | 104 | Pharmacological effect |
| Antiviral (RSV) | 0.97 | 1180 | Pharmacological effect |
| Antiviral (Rhinovirus) | 0.97 | 496 | Pharmacological effect |
| Antiviral (Trachoma) | 0.99 | 12 | Pharmacological effect |
| Anxiolytic | 0.9 | 18360 | Pharmacological effect |
| Apoptosis agonist | 0.84 | 11822 | Pharmacological effect |
| Apoptosis antagonist | 0.88 | 1018 | Pharmacological effect |
| Atherosclerosis treatment | 0.87 | 12764 | Pharmacological effect |
| Attention deficit/hyperactivity disorder treatment | 0.96 | 2935 | Pharmacological effect |
| Autism spectrum disorders treatment | 0.96 | 883 | Pharmacological effect |
| Autoimmune disorders treatment | 0.84 | 34030 | Pharmacological effect |
| Bipolar disorder treatment | 0.96 | 1636 | Pharmacological effect |
| Bone diseases treatment | 0.9 | 9778 | Pharmacological effect |
| Bone formation stimulant | 0.96 | 1259 | Pharmacological effect |
| Bronchodilator | 0.97 | 2993 | Pharmacological effect |
| Bulimia treatment | 0.98 | 157 | Pharmacological effect |
| CNS active muscle relaxant | 0.97 | 143 | Pharmacological effect |
| Cachexia treatment | 0.95 | 657 | Pharmacological effect |
| Cardioprotectant | 0.89 | 507 | Pharmacological effect |
| Cardiotonic | 0.92 | 9347 | Pharmacological effect |
| Cardiovascular analeptic | 0.94 | 19 | Pharmacological effect |
| Cell adhesion inhibitor | 0.96 | 1160 | Pharmacological effect |
| Cell adhesion molecule inhibitor | 0.97 | 685 | Pharmacological effect |
| Cell wall synthesis inhibitor | 0.95 | 1064 | Pharmacological effect |
| Chemopreventive | 0.94 | 505 | Pharmacological effect |
| Chemoprotective | 0.91 | 269 | Pharmacological effect |
| Choleretic | 0.97 | 389 | Pharmacological effect |
| Cholesterol absorption inhibitor | 0.98 | 237 | Pharmacological effect |
| Cholesterol synthesis inhibitor | 0.97 | 151 | Pharmacological effect |
| Chronic obstructive pulmonary disease treatment | 0.92 | 10717 | Pharmacological effect |
| Coagulant | 0.96 | 37 | Pharmacological effect |
| Cognition disorders treatment | 0.88 | 18179 | Pharmacological effect |
| Constipation treatment | 0.95 | 315 | Pharmacological effect |
| Contraceptive | 0.95 | 1522 | Pharmacological effect |
| Contraceptive female | 0.96 | 211 | Pharmacological effect |
| Contraceptive male | 0.96 | 378 | Pharmacological effect |
| Corneal wound healing stimulator | 0.96 | 25 | Pharmacological effect |
| Cushing's syndrome treatment | 0.98 | 401 | Pharmacological effect |
| Cystic fibrosis treatment | 0.94 | 2240 | Pharmacological effect |
| Cytostatic | 0.92 | 351 | Pharmacological effect |
| DNA intercalator | 0.96 | 1281 | Pharmacological effect |
| DNA synthesis inhibitor | 0.92 | 311 | Pharmacological effect |
| Dementia treatment | 0.96 | 316 | Pharmacological effect |
| Dependence treatment | 0.93 | 4962 | Pharmacological effect |
| Diabetic nephropathy treatment | 0.93 | 1083 | Pharmacological effect |
| Diabetic retinopathy treatment | 0.93 | 1340 | Pharmacological effect |
| Diuretic | 0.95 | 1491 | Pharmacological effect |
| Dysmenorrhea treatment | 0.97 | 497 | Pharmacological effect |
| Dyspepsia treatment | 0.97 | 332 | Pharmacological effect |
| Endometrios treatment | 0.97 | 1147 | Pharmacological effect |
| Erectile dysfunction treatment | 0.95 | 1766 | Pharmacological effect |
| Expectorant | 0.97 | 260 | Pharmacological effect |
| Female sexual dysfunction treatment | 0.98 | 716 | Pharmacological effect |
| Fibrosis treatment | 0.93 | 4088 | Pharmacological effect |
| Gastric antisecretory | 0.97 | 2271 | Pharmacological effect |
| Gastritis treatment | 0.95 | 361 | Pharmacological effect |
| Gastroesophageal reflux disease treatment | 0.97 | 809 | Pharmacological effect |
| Gaucher disease treatment | 0.98 | 356 | Pharmacological effect |
| Gout treatment | 0.96 | 1208 | Pharmacological effect |
| Growth stimulant | 0.96 | 116 | Pharmacological effect |
| HDL-cholesterol increasing | 0.97 | 1326 | Pharmacological effect |
| Hair growth stimulant | 0.96 | 1189 | Pharmacological effect |
| Heart failure treatment | 0.92 | 8675 | Pharmacological effect |
| Hematopoietic | 0.96 | 229 | Pharmacological effect |
| Hemostatic | 0.94 | 824 | Pharmacological effect |
| Hepatic disorders treatment | 0.9 | 7713 | Pharmacological effect |
| Hepatoprotectant | 0.93 | 1031 | Pharmacological effect |
| Huntington's disease treatment | 0.91 | 3104 | Pharmacological effect |
| Hypercalcemia treatment | 0.97 | 124 | Pharmacological effect |
| Hyperparathyroidism treatment | 0.98 | 337 | Pharmacological effect |
| Hypogonadism treatment | 0.99 | 199 | Pharmacological effect |
| Hypolipemic | 0.93 | 11143 | Pharmacological effect |
| Immunomodulator | 0.89 | 6199 | Pharmacological effect |
| Immunostimulant | 0.92 | 1564 | Pharmacological effect |
| Immunosuppressant | 0.89 | 5623 | Pharmacological effect |
| Immunosuppressant Cyclosporine-like | 1.0 | 19 | Pharmacological effect |
| Inflammatory Bowel disease treatment | 0.89 | 8780 | Pharmacological effect |
| Insulin sensitizer | 0.94 | 356 | Pharmacological effect |
| Irritable Bowel syndrome treatment | 0.94 | 3486 | Pharmacological effect |
| Keratolytic | 0.98 | 69 | Pharmacological effect |
| Leukotriene synthesis inhibitor | 0.98 | 957 | Pharmacological effect |
| Lipoprotein disorders treatment | 0.92 | 16114 | Pharmacological effect |
| Liver cirrhosis treatment | 0.95 | 838 | Pharmacological effect |
| Liver fibrosis treatment | 0.94 | 1348 | Pharmacological effect |
| Macular degeneration treatment | 0.94 | 1643 | Pharmacological effect |
| Male reproductive disfunction treatment | 0.94 | 2480 | Pharmacological effect |
| Menstruation disorders treatment | 0.96 | 604 | Pharmacological effect |
| Mental retardation treatment | 0.96 | 174 | Pharmacological effect |
| Metabolic disease treatment | 0.9 | 6536 | Pharmacological effect |
| Mood disorders treatment | 0.89 | 21316 | Pharmacological effect |
| Movement disorders treatment | 0.92 | 159 | Pharmacological effect |
| Mucolytic | 0.97 | 196 | Pharmacological effect |
| Multiple sclerosis treatment | 0.89 | 9330 | Pharmacological effect |
| Muscle relaxant | 0.95 | 607 | Pharmacological effect |
| Muscular dystrophy treatment | 0.94 | 725 | Pharmacological effect |
| Myasthenia Gravis treatment | 0.95 | 316 | Pharmacological effect |
| Myocardial infarction treatment | 0.91 | 2601 | Pharmacological effect |
| Myocardial ischemia treatment | 0.94 | 4665 | Pharmacological effect |
| Narcolepsy treatment | 0.98 | 384 | Pharmacological effect |
| Narcotic antagonist | 0.97 | 130 | Pharmacological effect |
| Neuropathy treatment | 0.94 | 546 | Pharmacological effect |
| Neutropenia treatment | 0.95 | 158 | Pharmacological effect |
| Non-steroidal antiinflammatory agent | 0.93 | 1296 | Pharmacological effect |
| Nootropic | 0.89 | 6850 | Pharmacological effect |
| Obsessive-compulsive disorder treatment | 0.96 | 478 | Pharmacological effect |
| Osteoarthritis treatment | 0.93 | 2406 | Pharmacological effect |
| Paget's disease treatment | 0.97 | 191 | Pharmacological effect |
| Pancreatic disorders treatment | 0.94 | 721 | Pharmacological effect |
| Peristaltic stimulant | 0.99 | 763 | Pharmacological effect |
| Phobic disorders treatment | 0.94 | 51 | Pharmacological effect |
| Photosensitizer | 0.96 | 86 | Pharmacological effect |
| Platelet aggregation inhibitor | 0.93 | 14493 | Pharmacological effect |
| Platelet antagonist | 0.93 | 7340 | Pharmacological effect |
| Postcoital contraceptive | 0.99 | 65 | Pharmacological effect |
| Postmenopausal disorders treatment | 0.99 | 330 | Pharmacological effect |
| Posttraumatic stress disorder treatment | 0.96 | 479 | Pharmacological effect |
| Premature ejaculation treatment | 0.98 | 235 | Pharmacological effect |
| Premenstrual syndrome treatment | 0.98 | 78 | Pharmacological effect |
| Prokinetic | 0.98 | 921 | Pharmacological effect |
| Proliferative diseases treatment | 0.9 | 290 | Pharmacological effect |
| Prostate cancer treatment | 0.9 | 12884 | Pharmacological effect |
| Prostate disorders treatment | 0.95 | 944 | Pharmacological effect |
| Prostatic (benign) hyperplasia treatment | 0.95 | 2958 | Pharmacological effect |
| Psychosexual dysfunction treatment | 0.95 | 498 | Pharmacological effect |
| Psychostimulant | 0.95 | 432 | Pharmacological effect |
| Pulmonary hypertension treatment | 0.94 | 1664 | Pharmacological effect |
| Radioprotector | 0.91 | 402 | Pharmacological effect |
| Radiosensitizer | 0.91 | 286 | Pharmacological effect |
| Raynaud's phenomenon treatment | 0.94 | 126 | Pharmacological effect |
| Renal disease treatment | 0.91 | 7803 | Pharmacological effect |
| Renal failure treatment | 0.95 | 1649 | Pharmacological effect |
| Respiratory analeptic | 0.91 | 204 | Pharmacological effect |
| Restenosis treatment | 0.95 | 2108 | Pharmacological effect |
| Restless leg syndrome treatment | 0.97 | 121 | Pharmacological effect |
| Retinopathy treatment | 0.95 | 470 | Pharmacological effect |
| Retinoprotector | 0.97 | 136 | Pharmacological effect |
| Rheumatoid arthritis treatment | 0.87 | 13219 | Pharmacological effect |
| Rhinitis treatment | 0.96 | 1818 | Pharmacological effect |
| Sepsis treatment | 0.93 | 1109 | Pharmacological effect |
| Septic shock treatment | 0.94 | 1891 | Pharmacological effect |
| Shock treatment | 0.95 | 218 | Pharmacological effect |
| Skeletal muscle relaxant | 0.95 | 392 | Pharmacological effect |
| Skin whitener | 0.95 | 476 | Pharmacological effect |
| Sleep apnea treatment | 0.96 | 244 | Pharmacological effect |
| Sleep disorders treatment | 0.94 | 5242 | Pharmacological effect |
| Spasmolytic | 0.92 | 2281 | Pharmacological effect |
| Stroke treatment | 0.88 | 12480 | Pharmacological effect |
| Systemic lupus erythematosus treatment | 0.93 | 2967 | Pharmacological effect |
| T cell inhibitor | 0.96 | 262 | Pharmacological effect |
| Thrombolytic | 0.95 | 1171 | Pharmacological effect |
| Tocolytic | 0.97 | 164 | Pharmacological effect |
| Tourette's syndrome treatment | 0.97 | 234 | Pharmacological effect |
| Transplant rejection treatment | 0.93 | 4927 | Pharmacological effect |
| Tumour necrosis factor alpha release inhibitor | 0.92 | 3753 | Pharmacological effect |
| Uric acid excretion stimulant | 0.97 | 913 | Pharmacological effect |
| Urinary incontinence treatment | 0.95 | 4136 | Pharmacological effect |
| Urolithiasis treatment | 0.94 | 1549 | Pharmacological effect |
| Urologic disorders treatment | 0.92 | 5806 | Pharmacological effect |
| Uterine relaxant | 0.98 | 129 | Pharmacological effect |
| Uterine stimulant | 0.96 | 51 | Pharmacological effect |
| Vascular (periferal) disease treatment | 0.92 | 3212 | Pharmacological effect |
| Vascular dementia treatment | 0.97 | 314 | Pharmacological effect |
| Vasculitis treatment | 0.96 | 465 | Pharmacological effect |
| Vasodilator | 0.92 | 2295 | Pharmacological effect |
| Vasodilator, coronary | 0.89 | 292 | Pharmacological effect |
| Vasodilator, peripheral | 0.89 | 225 | Pharmacological effect |
| Wound healing agent | 0.93 | 1425 | Pharmacological effect |
| Myocardial infarction | 0.85 | 896 | Adverse effect |
| Arrhythmia | 0.77 | 911 | Adverse effect |
| Cardiac Failure | 0.86 | 904 | Adverse effect |
| Hepatotoxicity | 0.71 | 684 | Adverse effect |
| Nephrotoxicity | 0.82 | 900 | Adverse effect |